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ABSTRACT
Thermoplastics can be used as a replacement or alternative for a variety of
medical and commercial products. The addition of halloysite nanotubes further enhance
the strength and functionality of the composite. The aim of this project was to evaluate
the capability polylactic acid (PLA) to be enhance with halloysite nanotubes and other
additives. We created a nanocomposite that offered similar stabilization to titanium
surgical plates but with the added benefit of bone generation through recruitment and
differentiation of mesenchymal stem cells. Varying amounts of PLA and
polycaprolactone were combined with growth factor doped halloysite nanotubes or
silicon nitrate then extruded into 3D printer filament. Once 3D printed from the custom
filament, the nanocomposite was subjected to mechanical and cell culture testing. Human
mesenchymal stem cells were exposed to the 3D printed nanocomposites and monitored
for osteogenic differentiation.
Additionally, metalized halloysite nanotubes (mHNTs) were added to PLA to
make an antibacterial 3D printer filament. Testing of both gentamicin loaded and
unloaded mHNTs embedded PLA nanocomposites was conducted on E. coli and S.
aureus. The PLA-mHNT filament was used to make a 3D printed antibacterial mask.
Blow-spun fibers made of PLA and mHNTs were used as the filter component, which
was added to the antibacterial mask to make an antibacterial respirator.
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CHAPTER 1
INTRODUCTION AND BACKGROUND
1.1 Industry Standard
With the gaining popularity of using biologically safe polymers in the medical
industry, we aim to develop an alternative option to titanium to fixate and stabilize
fractured bone. A polymer blend with an enhanced capability to aid in bone regeneration
could be the alternative that patients choose over titanium. Surgical implants to preserve
fractures have come a long way in a relatively short period. Alloys of vitallium and
stainless steel were used for several years but had drawbacks. Stainless steel was the
leading manufacturing material. However, testing showed that in many cases, it was
inferior to titanium [1]. Stainless steel screws tended to loosen or even breaking before
the fracture had been stabilized completely [2]. It was believed that infection played a
role in the failure of the stainless-steel implants, but these complications could occur even
without disease affecting the screws or surrounding bone [2]. Regardless of that fact, the
infection was not typically observed when titanium was used instead of stainless steel.
Additionally, titanium is about 40 percent lighter than stainless steel, making it
less taxing on the implant recipient [2]. The utilization of titanium made stainless steel
obsolete. The industry standard for reattaching tendons and ligaments has been relatively
the same for the past five decades. Titanium is a robust metal that is the leading implant
material when a high strength to weight ratio is needed to stabilize or fixate tissues or
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other objects in the body. Titanium surgical screws have been used to attach tissues to the
bone to closely mimic previous attachment’s structure, strength, and functionality of the.
These suture anchors are used to attach ligaments or tendons to the bone by drilling holes
directly into the existing bone. While titanium has been at the forefront of medical device
manufacturing, improvements can be made in designing medical devices.
1.2 Drawbacks to Titanium
Complications of titanium, when used in vivo, can range from but are not limited
to, chondrolysis, synovitis, osteolysis, or even device failure [3]. Chondrolysis and
osteolysis typically did not occur due to nanoparticles leaching over time or general wear
and tear of the titanium device. Instead, micro-shavings from the insertion of the titanium
screws enter adjacent cells and cause lysis. Once the structural integrity is restored
following the titanium implant fixation, implant removal becomes an option [4]. Ten
percent of titanium implant recipients have concerns about infection and thermal
sensitivity in European countries, while United States patients are wary about eventual
pain, soreness, tenderness, and disease [4]. In both cases, the 10 percent elect to have
their titanium implants removed [4]. Unfortunately, the removal of titanium implants is
not a simple task. Osseointegration, a condition in which bone grows over or onto the
implant, may occur, leading to the need to remove healthy bone to remove screws or
plates [4].
An additional complication could arise if implant breakage happens [5]. Frisken et
al. had data to support that implant failure may result in considerably more titanium
migrating to proximal lymph nodes. In the study, a 17 percent failure rate was observed
and attributed to increased torque and lack of screw taps or antibiotics [5]. Special care
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needs to be taken when using titanium braces in elderly patients due to an increased
possibility of the patient having higher levels of demineralized bone matrix [6]. Biofilms
can form on the titanium implants surface if their surface is not pristine and exhibits any
surface roughness [7]. Infections can arise from surface biofilms or compromised
immune capabilities due to a surface protein layer that is formed, which makes for a
suitable adhesion point for bacterial growth. Biofilms can be formed as soon as 30
minutes after implantation and an increase in thickness and colonies over time [8].
Growth of the bacterial biofilm can not only lead to infection but device weakening and
device failure as well.
1.3 Current Alternatives to Metal Implants
Advancements in medical technology have made the use of new materials for the
manufacturing of structural screws, stabilization plates, and wound sutures. Polymers
provide an alternative to the traditional metal in which these products were developed.
Careful considerations were taken into the selection process that determines which
polymers are used for in vivo applications. Special care and testing, in conjunction with
the Food and Drug Administration (FDA), ensure that the polymeric compounds that
comprise future implants are non-cytotoxic and biocompatible.
The ability to have a 3D printable substance that acts as a scaffold and is later
absorbed is the main focus of bioresorbable materials. The scaffold should have specific
properties such as controllable porosity, resorbability, and non-toxicity in an in vivo
environment.[9] Recently, research has been done on many different uses for
bioresorbable materials with the properties listed above. One area is in the world of
arterial disease repair. Cardiac stents are 3D printed out of bioresorbable materials to
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outperform the current metallic stents that are currently being utilized [10]. The new
technology is essential because, with the current stents, there are some adverse biological
side effects an device reliability issues that include but are not limited to in-stent
restenosis and late stent thrombosis [11].
Continuing with research to replace metallic structures with ones made of
polymers, Gaball et al. found a bioabsorbable bone plate that exhibited the same strength
yet more flexibility of similar bone plates made of titanium [12]. The research showed
that the polymers poly(L-lactide-co-D) and poly(L-lactide), when combined at a specific
ratio, could be used as a viable replacement option for stabilization of non-weight bearing
bones and joints such as the mandibular joint [12]. A study found that these polymers
were slightly osteogenic and were completely resorbed once replaced by newly grown
bone [13].
Other lines of research that bioresorbable materials are being utilized are in the
field of bone and tissue repair or replacement instead of solely fixating. Bioresorbable
polymeric scaffolds have an excellent potential for revolutionizing the way bones,
cartilage, and musculoskeletal tissues can be printed and replaced in the human body
[14]. The scaffolds would be used to promote cell growth of the host's own newly made
cells as a replacement for defective or absent tissues. These scaffolds are different from
the stabilization plates and screws because the original tissue is wholly or partially
removed and replaced with the 3D printed construct. The human body has a remarkable
ability to repair itself after it has sustained damage. Tissues tend to be more comfortable
and more quickly improved when compared to bone.
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1.4 Multifunctional Bioresorbable Implants
An implant can be deemed multifunctional if it performs more than a singular
primary purpose, for example, structure and active regeneration. To facilitate a
bifunctionality such as this, the bone plate would have to contain a substance that
promoted cell proliferation and differentiation. Various components that facilitate new
bone growth, which acts as a repair mechanism for the damaged bone. Some of these
components include growth factors or morphogenetic protein, and when coupled with an
adequate blood circulation near the site, new bone can be formed [15]. The particular
growth factors and morphogenetic protein typically being utilized for osteogenic and
chondrogenic development were TGF-β1, TGF-β2, TGF-β3, and BMP, respectively [15].
Several release mechanisms are available for releasing drugs, proteins, or growth
factors encapsulated in implants. Uhrich et al. (1999) researched different mechanisms to
release beneficial drugs encapsulated in polymers [16]. Diffusion controlled release
involves an insoluble polymer with a complex pore structure in which the encapsulated
drug must navigate to reach the surface to become active [16]. Flow regulated release is
mainly controlled by osmotic pressure in the host's body using a semipermeable polymer
[16]. External pressure is exerted onto the polymer, causing the polymer to release some
of the internal drugs, which it was embedded to equalize the pressure [16]. Typically,
controlled release involves a release of drugs at a constant rate. The polymer
encapsulated drug is controllably released through a system of premade channels in a
dissolvable polymer [16].
Studies have shown that the concept of bioresorbable polymers embedded with
growth factors such as TGF-β promotes bone growth and repair [17]. Bioresorbable
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materials can be made to release these growth factors with a precise dosage over some
time [15]. Furthermore, it was concluded that the soft tissue’s success rate to bone repair
could be improved by further exploring suturing implants composed of tri-calcium
phosphate and poly-etheretherketones.
The surface erosion mechanism closely resembles the mechanism that we are
aiming to achieve. Hydrolysis occurs for the outside moving inward, releasing the
encapsulated substance in specific dosages over some time [16]. The release of the
growth factors from halloysite over time due to the polymer’s biodegradation and the
subsequent resorption of the polymers' monomers is the main focus of my research.
1.5 Halloysite Nanotubes
1.5.1

Properties
Halloysite is a natural occurring aluminosilicate that is mined in several locations

around the world. It self-assembles into a hollow tube shape when exposed to water
known as a halloysite nanotubes (HNTs). HNTs have an inner lumen diameter of 15-20
nm, an outer diameter of 30-70 nm, and a length of 100-2000 nm [18]. The alumina layer
of the outer surface of the HNT is negatively charged and the surface of the inner lumen
has a silica layer that is positively charged. The charged surface of HNTs allow for
surface modification by attaching ions, ligands surfactants, or polyelectrolytes.
Substances with an overall positive or neutral charge such as antibiotics, proteins, and
hormones can be loaded inside the lumen. HNTs can hold approximately 10% by volume
most substances that are able to fit into their lumen via vacuum loading.
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1.5.2

Biocompatibility
Based on a numerous amount of research HNTs have been shown to be

biocompatible and non-cytotoxic [18]. Extensive research was conducted to explore the
use of HNTs as delivery systems for antimicrobial and chemotherapeutic agents due to
their sustained release over time. Cell cultures using fibroblast, pro-osteoblast, and
mesenchymal stem cells done by our research team have shown no cytotoxic effects due
to HNTs.
1.6 Growth Factors
1.6.1

TGF β1
Transforming growth factor-beta 1 (TGF β1) is one of many growth factors

released during bone resorption mediated by osteoclast. Growth factors are released
during this process of bone degradation to facilitate the formation of newer, more healthy
bone tissue [19]. Tienlinen et al. (1999) demonstrated that when TGF β1 was delivered
directly to an affected area by a degradable lactide pin, aided in bone formation [17].
TGF β1 is an abundant growth factor in the bone matrix that is released to stimulate the
migration of bone marrow-derived mesenchymal stem cells to the site of bone resorption
by the osteoclasts [19].
The effects of having an abundance of TGF β1 due to its release and activation by
osteoclasts have an impact on deterring activity of more osteoclast as a way of balancing
the degradation of bone. Metered distribution of TGF β1 is needed because overexposure
to TGF β1 over an extended time can lead to excessive bone thickening because of the
inhibition of osteoclast precursors, thus disrupting a healthy bone regeneration cycle [19].
Mutations in TGF β1 or the genes that encode for it are major factors in developing
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several diseases that can lead to deafness, blindness, or induced myopathy due to overly
dense bones [17], [19].
1.6.2

TGF β2
Using TGF β2 specific gene-probes, Millan et al. (1991) showed that the

expression of TGF β2 is present mainly in the chondroblast zones of long bones and not
in mature cartilage or areas of endochondral or intramembranous ossification [20].
Growth in these zones is characteristic of average pre-adulthood growth plate growth.
Similarly, Schmid et al. (1991) used a TGF β2 riboprobe to explore the expression of
TGF β2 and found that it was mainly present in growth zones of limbs in a study done on
mice during embryogenesis [21]. These studies suggest that TGF β2 is an initiator of
chondrogenesis and ossification in some bone regions. Additionally, cell proliferation
was elevated in coronal sutures and calvarial bones when exposed to TGF β2 [22].
1.6.3

TGF β3
The primary mesenchymal stem cell (MSC) response to TGF β3 is an increase in

cell proliferation. More specifically, James et al. (2009) showed that TGF β3 could affect
chondrogenesis by enhancing the chondroprogenitor cell expression [23]. Matsike et al.
(2015) developed a method using TGF β3 to differentiate MSCs into chondrocytes [24].
In both cases, TGF β3 was isolated and introduced to stem cells and successfully showed
cell proliferation and differentiation in the pathway that resulted in chondrogenic
formation. Kim et al. (2012) showed that a slow, sustained release of TGF β3 over nine
weeks had comparable results as the growth of cells exposed to a high concentration
immediately [25].
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1.6.4

BMP2
Bone morphogenetic proteins are widely used as a stem cell differentiator for

chondrogenesis and osteogenesis. Bone morphogenetic protein 2 (BMP2) is one of many
cytokines that can cause MSC to differentiate into osteoblasts when used in in vitro
experiments and induce in vivo bone growth [26]. BMP2 activates skeletal-related genes
for the formation of cartilage and bone in more than just mesenchymal cells [27]. BMP2
exposed stem cells showed early stages of commitment and differentiation to the
osteoblast phenotype [27]. Katagili et al. (1994) showed that BMP2 could differentiate
myoblasts into osteoblast when implanted into muscular tissue [28].
1.6.5

Silicon Nitride
Silicon nitride is being explored for its ability to differentiate cells into bone. It is

currently being used clinically due to its characteristic non-cytotoxicity and robustness
[29]–[32]. A study conducted by Guedes e Silva et al. (2007) showed osteogenic growth
due to silicon nitride through the presence of newly formed bone bridges that grew
towards and on the surface of the implant [29]. Pezzotti et al. (2017) confirmed through
histomorphometric analyses that the growth of new bone was due to silicon nitride
degradation and subsequent ion release as demonstrated by Fourier-transform-infrared
(FTIR), Raman, and X-ray photoelectron spectroscopy.
Silicon nitride particles have shown that they dissolve in polar liquids such as
phosphate-buffered saline or blood. Adsorption of the silicon nitride components into
blood plasma indicated an excellent acceptance of into the body with a relatively low
immune response [30]. The subsequent release of silicic acid and nitrogen compounds
from the breakdown of silicon nitride enhanced in vitro cellular activity [33]. Cappi et al.
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(2009) demonstrated the cytocompatibility of silicon nitride with live/dead staining of
human mesenchymal stem cells and mouse fibroblast cells in a cell culture study [34].
Not only is silicon nitride non-toxic, but it encourages cell adhesion, differentiation, and
normal proliferation [35]. The results of a survey conducted by Pezzotti et al. (2017)
connected osseointegration behavior with Si and N elements, which stimulated progenitor
cell differentiation and osteoblastic activity, ultimately resulting in accelerated bone
ingrowth [33]. Guedes e Silva et al. (2007) conducted a study using rabbits that revealed
that silicon nitride would induce differentiation of cells into bone tissue containing
osteocytes and osteons. In the 8-week study, the osteogenic process intensified at the 4week mark [29].
Additionally, silicon nitride has shown an ability to deter bacterial growth in vivo
while inducing the growth of healthy new bone tissue in rat studies [36]. During the
investigation, Webster et al. compared the potential to grow new bone around silicon
nitride, poly (ether ether) ketone (PEEK), and titanium both with and without inducing a
bacterial infection with Staphylococcus epidermidis [36]. While the study showed a
decrease in bone formation in the infected rats, there were no live bacteria adjacent to the
silicon nitride, unlike in the PEEK and titanium [36].
1.7 Design Elements
A combination of bioresorbable polymers, halloysite nanotubes and growth
factors comprised the device that aimed to replace the structural function of titanium.
Careful consideration was taken to include components that would add to the
effectiveness, either structurally or osteogenically. The research that was conducted
aimed to solve some of the problems associated with many of the current bioresorbable
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implants exhibits. Some of these challenges include a reduced ability to withstand shear
forces, raw material costs, and limitations with machining the implantable material. The
overall design elements were carefully chosen to develop a nanocomposite with adequate
strength and flexibility to fixate bone while being able to eventually dissolve as it
promotes osteogenesis or chondrogenesis, leading to full osteointegration, eventually
replacing the nanocomposite with newly grown bone.
Firstly, the ratio of which polymers to blend was investigated. This was important
because the nanocomposite, at the very least, must be able to stabilize the fractured bone.
Secondly, we decided which morphogens to use that would drive mesenchymal stem
cells to differentiate into the pathway that would eventually grow into bone or cartilage.
Individual proteins from the transforming growth factor superfamily were investigated
for possible inclusion in the nanocomposite design. The compound silicon nitride was
also used in this study to evaluate its effectiveness in differentiating stem cells into a
lineage that would result in the formation of osteocytes. The growth factors were to be
contained within the halloysite nanotubes, which acted as a biocompatible nanocontainer
and aided structurally within the nanocomposite.
The shape selection of the nanocomposite is of high importance to the implant’s
success once it is in vivo. Special consideration was taken to mimic the preexisting shape
of titanium bone fixation plates. To facilitate the stabilization of bone post-fracture,
several shapes of titanium are currently being used. Each has its inherent benefits.
Selecting the appropriate size, shape, and thickness of the titanium plate is crucial.
Accounting for loads on the device such as in vivo forces, interfacial tissue response,
applied exterior load, and load transmission to the interface was of grave concern [37].
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The use of screws instead of pins can be more beneficial to the implant recipient. A 10year study conducted by Karoussis et al. (2004) showed that having a lumen within a
screw-like shape was better than a hollow cylinder in terms of the overall success of the
implant [38]. They remarked that their patient sample showed a significantly higher
survival rate for the implant, lower instances of biological complications such as
mucositis and peri-implantitis.
One of the first factors that must be determined is whether the bone and,
therefore, the titanium implant, is weight-bearing. If a weight-bearing bone is fractured,
the implant must be more robust to withstand the weight of the individual once they are
healed. Non-weight bearing bone fractures can use thinner titanium plates, as their
strength typically does not need to be as high. The infill ratio and pattern of infill as
crucial as the shape of the nanocomposite. These two factors are what give the
nanocomposite its strength and ability to support cell growth. A proper balance of power
and the porosity, along with wall layers, had to be taken into consideration when
designing the nanocomposite. For this study, we only considered non-weight bearing
bone fractures. In each case, implant shape and the characteristics can have an impact on
the effectiveness of an implant over time. Extensive research has been done on the shape,
size, and composition of bone fixating surgical implants, as it will directly relate to the
success of the nanocomposite.

CHAPTER 2
3D PRINTING OVERVIEW
2.1 Types of 3D Printing
3D printing and additive manufacturing are terms that encompass several different
techniques to take a material and form it into a construct. These constructs are typically
designed using a rendering software that plans the printer’s every movement and
produces a printing code. Some of the techniques include powder bed inkjet printing,
stereolithography (SLA), selective laser sintering (SLS), electron beam melting (EBM),
and fused deposition modeling (FDM). Each printing technique has benefits, drawbacks
and limitations.
2.1.1

Powder Bed Inkjet Printing
In powder bed inkjet printing, the print head deposits a binding liquid, layer by

layer, in a predetermined pattern onto a bed of powder according to the computer-aided
design (CAD) instructions. The binding liquid is then covered in a thin layer of powder to
complete the section. The process is repeated until the model is complete, with each
successive layer bound to the previous layer. The next step is to de-powder the model,
which involves spraying, blowing, or washing the newly made model with a solvent or
air to remove the unbound powder. The main drawbacks for powder bed inkjet printed
objects are that they are highly porous, ununiform ,can be brittle, or may require
additional steps for curing [39][40]. Powder bed inkjet printing is not suitable for this
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application without further research done on the interaction of biodegradable binding
liquid and a powdered blend of polymer, growth factor and growth factor container.
2.1.2

Stereolithography
Stereolithography (SLA) is a 3D printing technique that uses a photochemical

process to bind oligomers and monomers to produce longer polymers. The light-sensitive
monomers and oligomers in liquid form are exposed to light, which crosslinks them,
forming a solid polymer. After a layer is photo-polymerized, the build platform is moved
back to the resin pool. A new layer of oligomer and monomer mixture is coated onto the
surface to begin the next layer. Hydrogels are being used to replicate soft tissues using a
similar process [41]. The main drawbacks of SLA are that the polymer that is produced
may not be uniformed, the final model may need additional curing, the resins are
typically not biodegradable, and hydrogel prints are typically not rigid [42], [43]. These
attributes rule stereolithography out as a means of manufacturing the desired
nanocomposite. Stress fractures or failure of the implanted device could occur due to
inconsistent polymer chains. Additional curing could damage growth factors embedded
within the nanocomposite.
2.1.3

Selective Laser Sintering
Selective laser sintering (SLS) is a technique that uses thermal energy supplied by

a focused laser beam as its primary mechanism to facilitate the sintering of substrates
such as nylon or polyamides. The powdered substrate is bound together at a single point
in space predetermined by 3D modeling software to construct a solid model using a beam
deflection system such as Galvano mirrors. This process should not be confused with the
similar technique of selective laser melting (SLM), which uses fully melted materials
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instead of powders. SLS has identical drawbacks as SLA, but models made using SLS are
typically less brittle than those made with the SLA printing method [44]. Selective laser
sintering was ruled out due to the thermal energy needed for the process. A
nanocomposite using silicon nitride could be made using this process.
2.1.4

Electron Beam Melting
Electron beam melting (EBM) is a high energy 3D printing technique in which

raw materials such as wire or metal powder are placed under a vacuum and fused. The
fusion is done by completely melting the substrate unlike in SLS. The process is typically
done at a higher temperature than the other 3D printing techniques which aids in reducing
porosity and increases mechanical properties. The main drawbacks are that EBM is
generally only used for the manufacturing of metal parts, like titanium braces, due to its
high-temperature demand [45], [46].
2.1.5

Fused Deposition Modeling
Fused deposition modeling (FDM) is the 3D printing technique that uses a

continuous spool of thermoplastic filament to manufacture models. The process entails
momentarily melting the thermoplastic polymer and directly extruding it onto the build
plate or the previously made layer. Precise heating and cooling of the thermoplastic are
vital in preventing warping, adding sufficient detail, and producing the desired porosity.
There are several different designs of FDM printers, but two design parameters offer
distinction between machines. The most important difference in design is the driving
mechanism to feed filament to the hot end of the extruder head. Direct drive is typically
less accurate than Bowden driven printers due to the added weight of the driving motor
attached to the printer head. In Bowden driven printers, a Bowden tube is connected
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between the feeding gear and the printer head. Direct drive printers typically have less
stringing when compared to Bowden driven printers. Stringing is misprinted, extra
material between two spans of a 3D print. Stringing can be minimized with fine-tuning of
temperature and filament retraction distance during printing. Figure 2-1 illustrates the
difference between the two printer head styles.
The second significant distinction between 3D printers is the number of printer
head freedoms. This term refers to the number of axes the print head is responsible for
covering, between 1 and 3. 2 degrees of freedom is typically more accurate than 1 or 3 if
one of the freedoms is in the z axis. The main drawback for FDM is that misprints are
common, prints are time-consuming, and there may be a need of printing supports. The
main advantages of FDM are that there is a broader range of materials that can be used
with this printing method, the printers are typically less expensive, and the printing
materials are less costly and readily available.
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Figure 2-1: Illustration of the difference between direct and Bowden driven 3D
printer head extruders.
2.2 Polymers
Polymers can be divided into two categories, biodegradable and nonbiodegradable. Non-biodegradable polymers withstand breakdown under normal
biological conditions. Biodegradable polymers are polymers that, when exposed to
biological conditions, begin to deteriorate through a process called hydrolysis. A
hydroxyl and carboxylic acid group is formed due to the hydrolysis of the ester bond of
the polyester backbone [47]. There is a cascade effect in which the breaking of one
monomer chain causes the breakdown of another. This is known as autocatalytic
hydrolysis in which the primary reaction for the breakdown of the polymer is facilitated
by the carboxylic end of the polymer at the ester bond [47]. Antheunis et al. (2010)
explained that the ester bonds of both the inner and outer chains are broken in bulk
hydrolysis [47]. Polymer hydrolysis can be categorized in two ways, bulk or surface.
Surface hydrolysis dissolves from the surface and moves inward, while in bulk
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hydrolysis, water penetrates through the surface of the polymer and dissolves the polymer
at an accelerated rate in comparison [16]. A diagram illustrating the difference between
the two types of erosions can be seen in Figure 2-2. In each case, it is the ester bond that
is cleaved that facilitates polymer degradation. However, the breaking of the ester bonds
is innately unpredictable yet somewhat proximal.

Figure 2-2: Illustration of the difference between bulk and surface erosion due to
polymer hydrolysis.
Biodegradable polymers can further be divided into the two sub-categories of
bioresorbable and non-bioresorbable. The distinction between the two is such that
bioresorbable materials are classified as having the potential to partially or entirely be
absorbed by cells and be utilized [48]. Several different analysis tests can determine the
hydrolysis of the bioresorbable polymer. Some of these tests include lactic acid release
testing, thermal property analysis and monitoring the decrease in molecular weight, all of
which would be done with an in vitro analysis before the implant was approved for in
vivo usage [49]. Studies have shown that the rate of hydrolysis highly depends on the
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starting molecular weight [49]. Higher molecular weight polymers tend to withstand
degradation longer than lower molecular weight polymers of the same material.
Due to the high molecular weight and machinability of poly-glycolic acid (PGA),
it is the ideal polymer to use to manufacture bioresorbable implants such as sutures.
Sutures made of PGA lose most of their mechanical properties, such as strength, in as
few as 2-4 weeks post-implantation [50]. However, when PGA is not combined with
other polymers, it tends to have a rapid degradation. Polylactic acid (PLA) is weaker in
comparison but has a slower rate of resorption than other readily used polymers such as
PGA [51]. PLA may be a better polymer than PGA as a stand-alone polymer when
considering bioresorbable thermoplastics for bone mending due to its slower degradation
rate. Its ability to maintain the original strength of the bone fixation device for a long
time is the leading rationale behind this conclusion. While PLA undergoes bulk
hydrolysis, it does so at a slower rate than PGA [16].
A combination of PGA and PLA would produce a polymer composite to make an
implant that has the strengths of both polymers. Even this polymer composite is not
perfect for all implant applications such as sutures, screws, scaffolds and stabilization
plates. The addition of polycaprolactone (PCL) further increases the strength and function
of the implant. PCL is a relatively inexpensive biodegradable polymer that has a low
melting point. PCL is the least rigid of the polymers mentioned above but holds its mass
in vivo for up to twice as long as the other two polymers [52]. Its ability to resist
degradation is ushering research in its ability to become a longer-term scaffold that can
release drugs, vaccines or steroids [53].
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The desired characteristics of multiple polymers can be combined to make a
thermoplastic superior to their constituents [54]. A nanocomposite can be constructed
using a blend of various polymers in various ratios to make a polymer blend or
copolymer. Polymer blends are created of two or more polymers that have been simply
blended into a filament or solvent cast. A copolymer is similar, but with the addition of a
polymerizing step that would combine two or more polymers into a new type of
polymer.
Post hydrolysis, the polymer is broken down as if it were any other naturally
occurring substance. PGA hydrolyses into glycine, while PLA hydrolyses into lactic acid
[55]. The excess glycine is either excreted or converted into glucose to be used later. The
excretion process for glycine is facilitated through urination. The other pathway to
eliminate the excess glycine is to convert it into water and carbon dioxide by the citric
acid cycle [55]. Once PLA is broken down into lactic acid, it is filtered out of the blood
by the liver or kidneys and expelled in urine. Lactic acid can also be filtered out of the
blood system by the liver and kidneys, where it follows a pathway to be metabolized by
the Cori Cycle, which produces glucose. PCL is converted into ꞓ-hydroxy caproic acid,
filtered out of blood and expelled in urine. PGA will not be used in this study due to the
inability to secure a supply of unprocessed polymer beads but will be included in future
experiments.
2.3 Infill
The wall thickness, infill pattern and infill density are more important than the
printing method of a 3D printed model. It is these three principles that will give the
model its density, rigidity, and overall robustness. The infill pattern and density are
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typically changed to adjust the print time, material consumption, density, and rigidity
[56]. The three most common infill patterns are the rectangular, concentric and
honeycomb patterns. Comparison and reliability test printing must be done to determine
the most favorable infill density and pattern for a given model on a 3D printing machine.
The CAD file that determines the overall shape of the model while the rendering
software is responsible for the infill pattern. The default settings of a printer are typically
predetermined by the printer unless otherwise changed [57]. The combination of the
CAD file and infill information is generally contained in the g-code file, which
communicates the internal and external patterns and build plate temperature, printer head
speed, filament retraction and cooling fan settings. Wall thickness is simply the number
of solid layers along the parameter of the printed model. The top and bottom layers of a
model are programmed differently from the wall thickness and can be as few as zero to
leave the model open at the bottom or top.

CHAPTER 3
POLYMER MIXTURE TESTING
3.1 Introduction
The blending of biodegradable polymers can enhance their ability to perform
mechanically [58]. The result of blending polymers can positively affect limitations
which include brittleness, stiffness, toughness, and rigidity. The strengthened restrictions
remain even while being enacted upon by outside stimuli such as temperature and
moisture variations. Mixing PLA and PCL has the effect of harnessing the strengths of
both individual polymers. The power of PLA and the flexibility of PCL combine to make
a polymer blend that is rigid enough to resist bending but flexible enough to bend without
breaking. The amount of flexibility in the polymer blend is directly correlated with the
amount of PCL within the composite. PCL acts as a plasticizing agent that can increase
the ability of a nanocomposite to withstand failure through enhanced ductility and
flexibility when under strain [58].
Additionally, composites made with both PLA and PCL have displayed a property
not seen in PLA or PCL in their unblended composites. Navarro et al. explained that the
shape memory effect is a behavior which involves of the ability to maintain or regain the
original shapes when acted upon by an outside force or condition [59]. Moreover, the
shape memory is facilitated by the manufacturing a nanocomposite that has 2 or more
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phases which have the responsibility to reobtain the original shape or the ability to
conform to a new form [59]. The process in which the polymers bend and reform is
known as programming and recovery. The programming and recovery process is
characterized by the temporary deformation from the original shape and then a
reformation step back towards the original shape [59]. It is thought that the multiphase
design is due to the differences in the glass transition of the two polymers.
Polymer mixing of different percentages have been tested in the past. Typically,
the blending process is done by mixing the polymers in heated mixer and pressed into a
mold to cool [60]. The extrusion method is also used, but it is done less often due to the
special equipment needed and difficulty to produce a uniformed product. Additional
additives can be added to the polymer mixture to give the finished polymer blend added
properties. Halloysite are one such material that has been shown to increase a variety of
physical properties [61][62]. While the position and orientation of the embedded HNTs
are somewhat unpredictable, their presence show several benefits such as increased
strength, thermal regulation, flame retardance, and a nanocontainer/carrier.
Halloysite nanotubes are naturally occurring, one dimensional nanomaterials that
resembles a hollow tube. The shape HNTs give them a high aspect ratio. Because of the
nature of its high aspect ratio, HNTs make great structural reinforcers for polymers. A
noticeable addition of strength has been documented by the addition of as low as 5% of
total weight composite material [62]. Polymers can see an increase in stiffness, strength,
and impact resistance simultaneously with the addition of HNTs [62]. The added
properties of halloysite make it an important additive in the manufacturing of bone
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implants, bone grafts, and bone cements [62]. In conjunction with the benefits listed
above, halloysite increase the composite’s ability to adhere to bone in in vivo studies [62].
The desired concentration of doped HNTs for this experiment was 5% and 10%.
A single coating using the method below was sufficient to achieve this percentage. A
double coating method was used to manufacture a polymer blend filament with 10%
doped HNTs. The methods differ because the outside surface of the polymers became
saturated with HNTs when coating with 5%, thus any additional HNTs would not coat
the polymer beads and simply agglomerated onto the mixing container. A higher
percentage of doped HNTs offer a higher ability to release dopant and possible structural
strength increase.
The experiments in this chapter were performed to design parameters to
manufacture an HNT embedded PLA/PCL blended polymer. The parameters include
HNT percentage, extrusion of filament temperatures, and polymer combinations. The
polymer preconditioning was kept constant, but the polymer composition was modified.
Different ratios of the polymer were tested to determine which would give the best
physical attributes to the final nanocomposite. The ratios of PLA to PCL were 80:20,
70:30, 60:40, and 100:0. The 100:0 polymer filament served as a reference to gauge the
difference in physical strength due to the addition of PCL. In each case, HNTs or silicon
nitride were embedded into each filament during the extrusion process. After making the
filament, each iteration of the filament was printed into a testing strip using the same
coding to ensure consistency. We hypothesize that a polymer blend of 80:20 PLA/PCL
will exhibit similar strength but increased flexibility when compared to the PLA filament.
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3.2 Methods and Materials
3.2.1

Growth Factor Hydration

Recombinant Human TGF β1, Recombinant Human TGF β3, and Recombinant Human
BMP2 were purchased from ProSpec (Rehovot, Israel). Recombinant Human TGF β2
was purchased from TonBo Bioscience (San Diego, US). Each growth factor protein was
hydrated according to the manufacturer’s specifications. Once hydrated, each respective
growth factor was diluted to make a 1 µg/ 10 ml solution in phosphate-buffered saline
(PBS).
3.2.2

Halloysite Loading
25 mL of PBS was placed in an autoclaved 100 mL beaker with a stir bar. 25 mL

of the hydrated growth factor and PBS solution was added to the PBS and stirred for 60
seconds. 5 g of halloysite nanotubes were slowly added to the beaker containing the
PBS/GF solution. The solution was stirred for 5 minutes to combine. The beaker was then
placed into the glass vacuum chamber and a 75 cm Hg vacuum was pulled for 5 minutes
and released. The vacuum and release were done five times, shaking every minute to
release trapped air bubbles. A final vacuuming step was taken for an additional 24 hours.
After the final vacuuming step, any remaining liquid was aliquoted and the doped
halloysite was dried in an incubator at 30°C for 24 hours. Figure 3-1 shows a visual
representation of the loading process.
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Figure 3-1 Diagram of the loading of halloysite nanotubes process. Red dots = growth
factors.
3.2.3

Polymer Preparation
The PLA used as a source in all blends was purchased from Sigma Aldrich and

had a molecular weight of 60,000. The PCL for each combination was purchased from
Aldrich Chemistry and had a molecular weight of 80,000. Each polymer was kept in a
tightly sealed contain to prevent uptake of water due to humidity.
3.2.3.1

PLA : Loaded HNTs Coating
PLA (50g) was added to a 1000 mL beaker and placed into an incubator at 45°C

for 24 hours. 200 µl of silicone pump oil (SPI Supplies) was pipetted onto the warm
polymer beads with a P200 micropipette. Parafilm was placed over the beaker’s opening
and the contents were vortexed then shaken in 60 seconds intervals respectively for a
total of 6 minutes to thoroughly coat the polymer beads. The coated beads were then
transferred into a clean 250 mL beaker to prevent access oil from coating the sides of the
beaker, thus taking away from the coating in the next step. 2.5 g of preloaded halloysite
nanotubes were added to the oiled polymer beads. Parafilm was place over the beaker.
The contents were vortexed and then shaken in 60 seconds intervals, respectively, for 6
minutes to thoroughly coat the polymer beads with the loaded HNTs. The HNT coated
polymer beads were placed in a 37°C incubator for 24 hours.
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3.2.3.2

PLA : Silicon Nitride Coating
PLA (50g) was added to a 1000 mL beaker and placed into an incubator at 45°C

for 24 hours. 200 µl of silicone pump oil was pipetted onto the warm polymer beads with
a P200 micropipette. Parafilm was placed over the beaker’s opening and the contents
were vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to
thoroughly coat the polymer beads. The coated beads were then transferred into a clean
250 mL beaker. 5 g of silicon nitride was pulverized using a mortar and pestle. 2.5 g of
the pulverized silicon nitride was added to the oiled polymer beads. Parafilm was place
over the beaker. The contents were vortexed and then shaken in 60 seconds intervals
respectively for 6 minutes to thoroughly coat the polymer beads with the silicon nitride.
The silicon nitride coated polymer beads were placed in a 37°C incubator for 24 hours.
3.2.3.3

PLA:PCL with Loaded HNTs Coating
In separate containers, 40 g of PLA and 10 g of PCL, 35 g of PLA and 15 g of

PCL, and 30 g of PLA and 20 g of PCL was added to a 1000 mL beaker, shaken to
combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm
was placed over the beaker’s opening and the contents were vortexed then shaken in 60
seconds intervals respectively for a total of 6 minutes to thoroughly coat the polymer
beads. The coated beads were then transferred into a clean 250 mL beaker. 2.5 g of
preloaded halloysite nanotubes were added to the oiled polymer beads. Parafilm was
place over the beaker. The contents were vortexed then shaken in 60 seconds intervals
respectively for 6 minutes to thoroughly coat the polymer beads with the loaded HNTs.
The HNT coated polymer beads were placed in a 37°C incubator for 24 hours.
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3.2.3.4

PLA:PCL with Silicon Nitride Coating
In separate containers, 40 g of PLA and 10 g of PCL, 35 g of PLA and 15 g of

PCL, and 30 g of PLA and 20 g of PCL was added to a 1000 mL beaker, shaken to
combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm
was placed over the beaker’s opening and the contents were vortexed then shaken in 60
seconds intervals respectively for a total of 6 minutes to thoroughly coat the polymer
beads. The coated beads were then transferred into a clean 250 mL beaker. 5 g of silicon
nitride was pulverized using a mortar and pestle. 2.5 g of the pulverized silicon nitride
was added to the oiled polymer beads. Parafilm was place over the beaker. The contents
were vortexed then shaken in 60 seconds intervals, respectively, for 6 minutes to
thoroughly coat the polymer beads with the silicon nitride. The silicon nitride coated
polymer beads were placed in a 37°C incubator for 24 hours.
3.2.3.5

PLA Double Coating
50 g of PLA was added to a 1000 mL beaker and placed into an incubator at 45°C

for 24 hours. 200 µl of silicone pump oil was pipetted onto the warm polymer beads with
a P200 micropipette. Parafilm was placed over the beaker’s opening and the contents
were vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to
thoroughly coat the polymer beads. The coated beads were then transferred into a clean
250 mL beaker. 2.5 g of preloaded halloysite nanotubes were added to the oiled polymer
beads. Parafilm was place over the beaker. The contents were vortexed then shaken in 60
seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer beads with
the loaded HNTs. The HNT coated polymer beads were placed in a 37°C incubator for 4

29

hours. The loaded HNT coated polymer beads were removed from the beaker and placed
into a clean 250 mL beaker, leaving any access HNTs in the former beaker. 300 µl of
silicone pump oil was pipetted onto the coated polymer beads with a P1000 micropipette.
Parafilm was placed over the opening of the beaker. The contents were vortexed then
shaken in 60 seconds intervals, respectively, for a total of 6 minutes to thoroughly coat
the precoated polymer beads. The coated beads were then transferred into a clean 250 mL
beaker. 2.5 g of preloaded halloysite nanotubes were added to the oiled precoated
polymer beads. Parafilm was place over the beaker and the contents were vortexed then
shaken in 60 seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer
beads with the loaded HNTs. The HNT coated polymer beads were placed in a 37°C
incubator for 24 hours.
3.2.3.6

80:20 PLA:PCL Double Coating
40 g of PLA and 10 g of PCL was added to a 1000 mL beaker, shaken to

combine, then placed into an incubator at 40°C for 24 hours. 200 µl of silicone pump oil
was pipetted onto the warm polymer bead mixture with a P200 micropipette. Parafilm
was placed over the opening of the beaker and the contents were vortexed then shaken in
60 seconds intervals respectively for 6 minutes to thoroughly coat the polymer beads. The
coated beads were then transferred into a clean 250 mL beaker. 2.5 g of preloaded
halloysite nanotubes were added to the oiled polymer beads. Parafilm was place over the
beaker. The contents were vortexed then shaken in 60 seconds intervals, respectively, for
a total of 6 minutes to thoroughly coat the polymer beads with the loaded HNTs. The
HNT coated polymer beads were placed in a 37°C incubator for 4 hours. The loaded
HNT coated polymer beads were removed from the beaker and placed into a clean 250
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mL beaker, leaving any access HNTs in the former beaker. 300 µl of silicone pump oil
was pipetted onto the coated polymer beads with a P1000 micropipette. Parafilm was
placed over the opening of the beaker. The contents were vortexed then shaken in 60
seconds intervals, respectively, for 6 minutes to thoroughly coat the precoated polymer
beads. The coated beads were then transferred into a clean 250 mL beaker. 2.5 g of
preloaded halloysite nanotubes were added to the oiled precoated polymer beads.
Parafilm was place over the beaker and the contents were vortexed then shaken in 60
seconds intervals, respectively, for 6 minutes to thoroughly coat the polymer beads with
the loaded HNTs. The HNT coated polymer beads were placed in a 37°C incubator for 24
hours.
3.2.4

Filament Extrusion
Once the desired polymer blend was coated and heated for 24 hours, it was ready

to extrude. The drying step must not be skipped to ensure the proper extrusion of the
polymer beads into a filament with minimal air bubbles and entrapped water. A “Noztek
Pro Filament Extruder” was used to extrude a 1.75 mm filament with a desired standard
de of no more than 0.05 mm. There was no feed rate adjuster, so the temperature to
achieve the specific desired filament thickness differed for every blend and additive. The
extrusion temperatures are displayed in Table 3-1. To prevent contamination, of air
bubbles or cleaning solvent from being embedded within the newly made filament, the
first 5 meters were discarded as per the manufacturer’s instructions. The filament was
then wound into a spool and placed into a Zip Loc plastic freezing bag and placed into
the freezer at -20°C until it was used for printing.
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3.2.5

Three-Point Bend Tests

3.2.5.1

Bend Tests
Each respective iteration of filament was 3D printed into the shape depicted in

Figure 3-2. The wall thickness on the print was 3 layers while the top and bottom
surfaces were 2 layers thick. The shape was created using TinkerCad and the G-code was
written using Ultimaker Cura 3.5 software. Elasticity test were preformed using a
CellScale UniVert modulator (Ontario, Canada). Each sample was placed onto the
Univert testing platform and the middle point was lowered until the load was 0.02 N of
force. In this test, the middle arm was moved down to 3cm at a speed of 1cm/s and
retracted at 1 cm/s for a series of 5 bends for each sample. Tests were also done to a
depth of 5 cm at a speed of 1 mm/s and retracted at 1 cm/s.

Figure 3-2: Rendering of the shape to make the 3D print for the 3-point bend tests. Each
square represents 1 mm2. The dimensions are 56 mm x 8 mm x 2.5 mm.
3.2.5.2

Failure Tests
Each sample was printed in the same shape as the bend tests. With a similar setup

as the 3-point bend test, the failure test was performed on the CellScale Univert
modulator. As before, the sample was placed on the bottom 2 points and the middle
threshold was lowered to a load of 0.02 N of force.
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The break test was performed by moving the middle arm down at a rate of 1cm
per second until the sample failed. For the safety of the machine, a maximum distance of
10cm was the programmed stopping point if a failure did not occur. Testing was done on
non-degraded and degraded samples. The non-degraded samples were subjected to
testing 1 day after printing. The degraded samples were exposed to PBS for 6 or 12
weeks at 37°C. During the degradation period, the nanocomposites were vortexed for 10
seconds every 48 hours. Non-degraded and degraded samples were compared to chart the
loss of strength due to degradation.
3.2.6

Nanocomposite Degradation for Bend and Failure Tests
The nanocomposite was printed using the “Creality Ender 3 Pro” 3D printer into

the bowtie shape of the bend and failure tests. Once the nanocomposite was printed, it
was stored in the freezer at -20°C until all nanocomposites were ready to undergo
degradation. The nanocomposites were then washed with deionized water and placed into
falcon tubes with 15 mL of PBS and placed into an incubator at 37°C. The samples were
vortexed every 2 days for a degradation time of 20 weeks.
3.2.7

Degradation Testing
The degradation profiles of each blend of the nanocomposite were also

investigated. The tests were performed by placing each 3D printed nanocomposite
composition into separate sample tubes containing 15 mL of PBS at 37°C. Each sample
was vortexed every 48 h to ensure even degradation. The design was made to more
closely mimic the outer surface that the nanocomposite would have in vivo once the
nanocomposite was implanted and held in place as a brace and screw combination.
Printing the nanocomposite with the screw holes would have given water an ability to
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hydrolyze the nanocomposite from surfaces that would have been plugged. Figure 3-3
show the shape of the 3D printed nanocomposite that was degraded for this study. Cells
prefer a textured surface to attach rather than smooth surface. A textured surface was
created to aid in cell adhesion. The nanocomposite was dipped in 5M sodium hydroxide
for 1 minute. Readings of 6 different samples were taken every 4 weeks for a total of 20
weeks. The NanoDrop 2000c spectrophotometer was used to read the absorbances of the
released monomer in a quartz cuvette. To monitor the hydrolysis of each polymer over
the 20 weeks, PLA and PCL were analyzed at 230nm for PLA and 270nm for PCL. PBS
was used in place of commonly used simulated body fluid (SBF) because of the long
period of time used to degrade the nanocomposite. SBF needs to be changed periodically
due to rising pH levels unlike PBS.

Figure 3-3 Rendering of the shape to make the 3D print for the degradation and elution
tests. Each square represents 1 mm2. The maximum dimensions are 25 mm x 14 mm x 3
mm.
3.2.8

Statistical Analysis
Statistical analysis was performed using Microsoft Excel Analysis ToolPak plugin

and Origin 9.6. All experiments were done in triplicate and with one-way analysis of variance
(ANOVA) with p < 0.05 as the significance level was utilized for statistical analysis.
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Statistically significant data was reported (p < 0.05), and all the results were reported as mean
± standard deviation (p < 0.05, n=3) unless otherwise specified.

3.3 Results and Discussion
3.3.1

Extrusion Temperature
The objective of the first experiment was to determine the optimum temperature

for extrusion of filaments with 5 or 10% additive addition. Using single and double
coating methods that distributes additive onto polymer beads, a filament was made using
the same extruder but at different extrusion temperatures. Table 3-1 shows each
extrusion temperature and the diameter of each filament.
Table 3-1 The extrusion temperature and diameter of each filament composition.
Filament measurements were taken every meter. 30 measurements were taken to
determine deviation.
PLA:PCL
100:0
100:0
100:0
100:0
80:20
80:20
70:30
70:30

Additive
HNT
SiN
Double HNT
Double SiN
HNT
SiN
HNT
SiN

Temperature
180°C
170°C
184°C
170°C
175°C
172°C
175°C
172°C

Diameter
1.75mm
1.75mm
1.75mm
1.75mm
1.75mm
1.75mm
1.75mm
1.75mm

Tolerance
0.03
0.02
0.02
0.01
0.01
0.02
0.03
0.01

60:40
60:40

HNT
SiN

174°C
171°C

1.75mm
1.75mm

0.02
0.01

Although the 1.75 mm filaments were made, the double-coated filament
containing 10% additive was brittle and noticeable rough once extruded. However, the
single-coated 5% additive filaments were flexible, and the surface was smooth. For 3D
printing, the double coated 10% HNT or silicon nitride were not included in future
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experiments due to the filament’s abrasiveness and brittleness. The ability to make 3D
prints was compromised due to the physical conditions of the manufactured filament.
Only the filaments with 5% HNT or 5% silicon nitride were used for the duration of the
later experiments.
3.3.2

Strength Testing

3.3.2.1

3-cm Bend
Bones are designed to distribute applied mechanical loads; therefore, a brace

should withstand applied stresses and strain. The 3cm bend test was more of an extreme
bend than bones typically receive. Each individual blend showed a decrease in strength
over time with repeated bends. Figure 3-4 show the average of 3 different
nanocomposites of each polymer blend. The error bars represent the standard deviation of
each maximum force at 3cm of bend. The slopes of the peaks represent the average loss
in the amount of force needed to reach a 3cm bend. A more negative slope of the
trendline represents a higher degree of loss strength. The slope of the 80:20 blend was
closer to zero, meaning that it showed the least amount of strength lost sue to repeated
bending. The over lay of the graphs in Figure 3-5 shows that the 80:20 needed similar
force to bend the nanocomposite.
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Figure 3-4: The graphs of the force exerted upon the nanocomposites during the 3 cm 3point bend test for (A) PLA, (B) 80:20, (C) 70:30, and (D) 60:40 polymer blends. Error
bars represent the standard deviation of the peaks. (n=3)
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Figure 3-5: A composite of the forces exerted onto the nanocomposites during the 3point bending test. Each line represents the average of 3 tests.
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A composite of the force graphs for the 3cm 3-point bend test of the
nanocomposite is shown in Figure 3-5 demonstrates that with the addition of more PCL,
less force is needed to reach the maximum bend length of 3cm. The graph represents an
average of the forces acted upon of 3 samples per polymer blend. The outcome was
predicted due to the plasticizing nature of PCL. Remarkably, the 80:20 combination
showed similar strength to the PLA nanocomposite but had less loss of power after
bending. The elastic effect was seen in all PCL containing nanocomposites. While the
addition of PCL past 20% showed a decrease in force needed to bend, the
nanocomposite’s recovery and ability to sustain supplemental stress was heightened. The
80:20 blend offered the best combination of strength and flexibility with regard to the 3point bend test.
3.3.2.2

5-cm Bend
A lack in reflex was observed in each iteration of the nanocomposite following

the maximum bend distance. The non-linear line of the down slope of the force graph in
Figure 3-6 illustrates this fact. If an even rebound was observed, there would be less of
an immediate drop in force. A 3 cm bend is an extreme deformation for a bone, much less
a fixation plate, but a 5 cm bend was tested to see if the effects of the lag in reformation
would remain constant or be exacerbated. The results of the 5cm bend test can be seen in
Figure 3-6.
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Figure 3-6: A composite of the forces exerted onto the nanocomposites during the 5cm
3-point bending test. Each line represents the average of 3 tests.
The 5cm bend test showed a lower ability to reform after an extreme bend,
regardless of the amount of PCL present in the blend. Similar to the 3 cm bend test, the
80:20 blend showed identical properties as the PLA nanocomposite. Remarkably, a
massive overall loss in strength was not observed. The evidence of this is in the force
peaks. While there is a decrease such as seen in the 3cm bend, it was not as drastic.
3.3.2.3

Break Tests
Complete nanocomposite failure was tested on newly printed nanocomposites and

nanocomposites degraded for 6 or 12 weeks. The comparison of each respective blend
concerning degradation is displayed in Figures 3-7, 3-8, and 3-9. In these Figures, each
dot represents an actual failure, and the lines represent the average forces and distances
for the three test that lead to the three failures.
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Figure 3-7: Force (N) to break the nanocomposite after a degradation period of 0 weeks.
Each line is the average of exerted force. Each dot is the maximum force applied with
respect to distance before failure.
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Figure 3-8: Force (N) to break the nanocomposite after a degradation period of 6 weeks.
Each line is the average of exerted force. Each dot is the maximum force applied with
respect to distance before failure.
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Figure 3-9: Force (N) to break the nanocomposite after a degradation period of 12
weeks. Each line is the average of exerted force. Each dot is the maximum force applied
with respect to distance before failure.
The newly printed PLA and 80:20 blend had comparable strength, while the other
combinations showed that the increase in PCL percentage made the nanocomposite
weaker. The nanocomposites that were degraded for 6 weeks all showed a large decrease
in strength except for the 70:30 blend. Due to the unpredictable nature of constructing the
filament, a small section may have been composed of more PLA than desired. A PCL
rich surface would have a slower degradation than one that had PLA more towards the
surface. PLA rich filament sections could allow the nanocomposite to behave more like
PLA. The nanocomposites that were exposed to PBS for 12 weeks show a much lower
ability to resist force. It is speculated that the PCL in the blends is becoming either stiff or
brittle due to the exposure to PBS thus losing their elastic properties. PLA experienced
less loss of strength compared to the PCL containing nanocomposites. However, it should
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be noted that every PLA nanocomposite had a catastrophic failure in which it was
completely broken in half. PCL containing nanocomposites remained in a single piece.
The trend of having a general weakening effect as the percentage of PCL
increased was once again observed. For a comparison of work needed to cause failure,
and the standard deviation of each blend, see Figures 3-10, 3-11, and 3-12.
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Figure 3-10: Average work needed to destroy the nanocomposite after a degradation
period of 0 weeks. Error bars represent the standard deviation. (n=3)
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Figure 3-11: Average work needed to destroy the nanocomposite after a degradation
period of 6 weeks. Error bars represent the standard deviation. (n=3)
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Figure 3-12: Average work needed to destroy the nanocomposite after a degradation
period of 12 weeks. Error bars represent the standard deviation. (n=3)
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The loss in strength of each respective blend can be seen in Figure 3-13. Each
point represents the average work needed to break three nanocomposites after
degradation over the 0-, 6- or 12-week periods. The slope of the trendline illustrates the
degree of loss of strength and can be seen in the bottom left corner of the graph. As
before, the more negative the slope of the trend line, the higher the strength loss.
100:0 y = -0.3274x + 1.7418
80:20 y = -0.5422x + 2.2007
70:30 y = -0.4173x + 1.905
60:0 y = -0.3674x + 1.5834
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Figure 3-13: Graph of work needed to destroy each blend of nanocomposite after
degrading for 0-, 6-, and 12-weeks. The slope of each line represents the trendline of each
nanocomposite. Error bars represent the standard deviation. (n=3 for each point)
Unlike before, the strength loss was from degradation due to polymer hydrolysis
did not favor the 80:20 blend. The 80:20 blend showed the least retention of strength after
degradation, while the nanocomposite without PCL showed the best retention followed
by the 60:40 blend. Regardless of the trend, the 80:20 blend was one of the top
performers for each degradation period. The steep slope could be attributed to the higher
strength of the non-degraded nanocomposite. This observation can be coupled with the
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nanocomposite degrading and becoming as weak as the other nanocomposite blends over
time due to degradation.
3.3.3

Degradation Testing
Due to the performance of the strength tests, a decision was made to exclude the

70:30 and 60:40 blends from further tests. A nanocomposite consisting of these two ratios
would not be able to produce a nanocomposite with enough strength and flexibility to be
effectively used to fixate bone. Degradation testing was performed on the 80:20 blend to
chart the hydrolysis of each respective polymer into monomers. PLA was also tested for
comparison purposes. The absorbance of the lactic acid monomers that resulted from the
hydrolysis of PLA can be seen in Figure 3-14. Figure 3-15 and Figure 3-16 show the
absorbances of lactic acid and ꞓ-hydroxy caproic acid in PBS that was formed due to the
hydrolysis of the 80:20 blend.
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Figure 3-14: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a
20-week period for the PLA nanocomposite. Error bars represent standard deviation.
(n=6)
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Figure 3-15: Absorbance recorded at 230 nm to characterize lactic acid in PBS over a
20-week period for the 80:20 blend nanocomposite. Error bars represent standard
deviation. (n=6)
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Figure 3-16: Absorbances recorded at 270 nm to characterize ꞓ-capronic acid in PBS
over a 20-week period for the 80:20 blend nanocomposite. Error bars represent standard
deviation. (n=6)
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See Figure 3-17 to properly gauge the total amount of polymer hydrolysis and
release of monomers from the 80:20 blend. The intensities of absorbance were combined
to give a comparison to the lactic acid released by the PLA nanocomposite.
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Figure 3-17: Absorbance values of the combined ꞓ-capronic and lactic acid in PBS over
a 20-week period for the 80:20 blend nanocomposite. Error bars represent the combined
standard deviations. (n=6)
The amount of monomer in solution for the PLA nanocomposite were higher than
the monomers released from the 80:20 blend. A comparison can be seen by looking at
Figures 3-18. PCL is known to undergo hydrolysis at a slower pace when compared to
PLA, and the results of this degradation study supported that statement. A comparison of
the slope of each degradation rate further supports that PLA degrades faster that the
PLA:PCL mixture.
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Figure 3-18: Graph showing the values associated with the hydrolysis of each
nanocomposite. Error bars represent the standard deviation. (n=6)
3.4 Discussion and Conclusions
Our hypothesis was supported by the test performed in the previous experiments.
PCL has been shown to increase PLA’s flexibility in every test performed in this
experiment. The elastic gain did not outweigh the strength lost due to the addition of PCL
past the 20% threshold. A blend of PLA and PCL has similar strength and increased
flexibility when compared to PLA alone. To manufacture usable filament with additives,
the amount of additive must be kept to a certain percentage to create a uniform filament,
suitable for 3D printing. It was found that extruding a filament with 10% HNT or silicon
nitride negatively affected the filament’s quality, making it unusable for 3D printing
using our printers.
The amount of monomer in solution supports the expected behavior of the
hydrolysis process of each polymer. PLA dissolves at a much faster rate than PLC. We
can see that this principle was upheld even when the two polymers were blended and
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extruded into a single filament. The combined monomer in the solution of the 80:20
blend at 20 weeks of degradation was similar to the amount of monomer released into the
solution of the 100:0 polymer after 12 weeks of degradation. A slower degradation gives
the nanocomposite an ability to stabilize the fracture for a longer period while new bone
is being formed. The additional time can increase thickness of bone due to a prolonged
exposure to the growth factors that are eluted from the nanocomposite. We suspect that if
the nanocomposites with higher levels of had been tested in parallel for degradation rate,
it would have had a slower rate than the 80:20 blend.
Future studies will be conducted with the addition of PGA to further fine-tune the
nanocomposite’s strength, flexibility and degradation for a specified time length. The
current problem of a readily available supply of PGA continues to exist. To further refine
the nanocomposite, similar tests can be performed with PLA and PCL ratios that are
close to the 80:20 blend that had the best outcome of the blends tested in this experiment.
The ratios of interest for future studies of PLA:PCL:PGA are 80:15:5, 80:10:10, 75:20:5,
70:20:10 and 75:15:10, respectively. Moreover, an additional test can be performed to
evaluate a condition that was not tested in this set of experiments, torque. The
nanocomposite could be expected to resist rotational force due to normal bodily
movements. An examination of the force needed to rotate the nanocomposite by a certain
degree could be warranted. The amount of rebound to return to the original shape after
torque is applied. Lastly, the rotation torque needed for the nanocomposite to fail would
be tested. These torque tests can be performed on PLA, the 80:20 blend as well as any
additional new blend.

CHAPTER 4
CELL CULTURE STUDIES
4.1 Introduction
Intercellular communication between cells and their environment can be enabled
by cellular adhesion [63]. Leyva-Leyva et al. (2015) linked cell adhesion achieved
throughout focal adhesions and osteogenic differentiation via adhesion components using
CD105+ and CD105- human mesenchymal stem cells [63]. CD105 is also known as
Endoglin, a cell surface glycoprotein that is part of the TGF beta receptor complex [64].
Smad2 signaling due to Endoglin expression has lead synovium-derived mesenchymal
stem cells to undergo chondrogenesis [65]. Several pathways, such as Wnt, MAPK,
Smad2/3, and β-catenin, have been researched as signaling pathways that promote
chondrogenesis or osteogenesis in conjunction with members of the TGF beta super
family [66].
Cellular attachment and exposure to the specific growth factors used in this
experiment were analyzed for the ability to foster the growth of osteoblasts and
chondroblasts. Alizarin Red S staining and cell viability/cytotoxicity assays were used at
predetermined intervals of exposure to the nanocomposites that were eluting the growth
factors, to analyze cells. Initial testing was done on the nanocomposites to determine the
amount of growth factor that was released from the nanocomposites. The quantification

49

50

of the released growth factor gave insight into the amount of growth factor expected to be
released and exposed to the stem cells during the cell culture studies.
Meinel et al. (2004) observed that MSCs exhibited calcium deposits, which
increased over time, starting 3 weeks after culturing began. It was noted that the between
weeks 2 and 3 of the culture, an increase in cell cluster sizes and intensity of staining
indicating higher calcium deposits was observed suggested the initiation of bone
formation [64].
We hypothesized that our nanocomposite would release growth factor or silicon
nitride over time and be non-cytotoxic to mesenchymal stem cells while promoting
osteogenic differentiation. The release of the morphogenic agent contained within the
polymer nanocomposites have been proven to foster cell proliferation, migration and
differentiation due to direct exposure.
4.2 Methods
4.2.1

FITC/BSA Release Study
The release characteristics for the 3D printed nanocomposite were tested using

FITC tagged bovine serum albumen (FITC/BSA) as a surrogate for growth factors.
FITC/BSA is less expensive and quantitative analysis upon using a spectrophotometer is
simple and straightforward. HNTs were loaded with FITC/BSA and 3D printed in the
same manner as the growth factor containing HNTs. The FITC/BSA/PLA filament was
3D printed into the dog bone shape as described in chapter 3’s degradation testing using
the Creality Ender 3 printer.
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4.2.1.1

Making FITC/BSA Filament
A solution of 10 µg/mL of FITC/BSA in PBS was prepared. Halloysite nanotubes

(5 g) were slowly added to a 100 mL beaker containing the FITC/BSA/PBS solution. The
solution was stirred for 5 minutes to combine. The beaker was then placed into a glass
vacuum chamber and a 75 cm Hg vacuum was pulled for 5 minutes and released. The
vacuum and release were repeated 5 times, shaking every minute to release trapped air
bubbles. A final vacuuming step performed for an additional 24 hours. After the final
vacuuming step, any left-over liquid was aliquoted and washed 3 times with PBS to
remove any FITC/BSA that remained on the surface. The doped halloysite was then dried
in an incubator at 30°C for 24 hours.
PLA (50 g) was added to a 1000 mL beaker and placed into an incubator at 45°C
for 24 hours. 200 µl of silicone pump oil (SPI Supplies) was pipetted onto the warm
polymer beads. Parafilm was placed over the opening of the beaker and the contents were
vortexed then shaken in 60 seconds intervals respectively for a total of 6 minutes to
thoroughly coat the polymer beads. The coated beads were then transferred into a clean
250 mL beaker to prevent access oil from coating the sides of the beaker, thus taking
away from the coating in the next step. FITC/BSA doped halloysite nanotubes (2.5 g)
were added to the oiled polymer beads. Parafilm was place over the beaker and the
contents were vortexed and shaken in 60 seconds intervals respectively for a total of 6
minutes to thoroughly coat the polymer beads with the FITC/BSA doped HNTs. The
HNT coated polymer beads were placed in a 37°C incubator for 24 hours. A 1.75 mm
filament was made with an extrusion temperature of 180°C.
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4.2.1.2

Nanocomposite Elution
The FITC/BSA elution tests were performed by placing each 3D printed

nanocomposite discs into separate sample tubes containing 2 mL of PBS at 37°C. Each
sample was vortexed every 48h to ensure even degradation. The design was made to
more closely mimic the outer surface that the nanocomposite would have in vitro once
the nanocomposite was glued to a well of a 48 well cell culture plate. Cells prefer a
textured surface to attach rather than smooth. To mimic the conditioning that the
nanocomposite would be subjected to as a way of aiding in cell adhesion, the
nanocomposite surface was slightly degraded to add texture. The nanocomposite was
dipped in 5M sodium hydroxide for 1 minute. Each nanocomposite was washed with
water and dried before degradation.
4.2.1.3

FITC/BSA Concentration Collection
Forty-two 3D printed nanocomposites were degraded as described in the previous

section. Measurements were taken every 4 days from 6 different samples for a total of 4
weeks. Samples were vortexed for 10 seconds prior to collection. After 2 mL of eluted
FITC/BSA in PBS was collected and, the sample discarded. The sample liquid was
analyzed within one hour after collection to prevent FITC/BSA degradation due to light
interaction.
4.2.1.4

FITC/BSA Calibration Curve
A calibration curve was made using FITC/BSA and PBS. 1 mg of FITC/BSA was

added to 100 mL of PBS and mixed well to combine to get same amount of FITC/BSA
that was in solution that was used for vacuum loading HNTs. Further dilutions from the
stock 10 µg/mL FITC/BSA were used to complete the calibration curve. A series of serial
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dilutions was made and measured from a concentration of 10 µg/mL down to 15.6 ng/mL
using the Nanodrop 200c spectrophotometer. The results are displayed on Figure 4-1.
4.2.2

Cell Culture Media
Cell culture media was designed to give adequate nutrients to stem cells to

support proliferation and future differentiation. 400 mL of Dulbecco’s Modification of
Eagle’s Medium (DMEM) (Corning) with 4.5 g/L glucose, L-glutamine and sodium
pyruvate was added to a sterile flask. 47.5 mL of fetal bovine serum (FBS)(Biowest) was
then added to the DMEM. 2.5 mL of penicillin streptomycin solution (Corning) was the
last media ingredient added to the flask prior to vacuum filtration to remove any large
particles or contaminants. The solution was labeled “complete media” and placed into the
refrigerator for storage.
4.2.3

Cell Culture Proliferation
StemPro human adipose derived stem cells were used as a cell source for this

study. The initial cell plating was done on a ThermoFisher T-75 culture flask placed into
a 37°C incubator with 5% CO2. Once the confluency was between 90-95%, the cells were
passaged for further proliferation. Depleted media was removed, 1 mL of 0.25% trypsinEDTA was added to the flask and place into the incubator for 75 seconds. The flask was
then gently tapped to detach any cells that remained attached to the flask. 10 mL of media
was added to the flask and mixed to suspend the cells throughout the media. 1 mL of the
cell and media mixture was added to a new culture flask. An additional 9 mL of media
was added to each culture flask, the cap was applied loosely, and placed back into the
incubator.
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4.2.4

Nanocomposite Printing and Preconditioning
Each nanocomposite iteration was printed using the Creality Ender 3 printer. The

discs had 50% infill and were cylindrical in shape. Before attaching them to the base of a
48 well plate, each nanocomposite was preconditioned by dipping them in 5M sodium
hydroxide for 1 minute. Post preconditioning, the nanocomposites were washed with
water thrice and dried. Each nanocomposite was plated into individual wells of a 48 well
plate and secured with superglue. The superglue was allowed to cure for 2 hours before
the plates containing the nanocomposites was placed under UV light for 30 minutes to
kill any bacteria that may have landed on the surface.
4.2.5

Addition of Cells 48 Well Plate
Media was removed from each cell culture flask and discarded. 1 mL of 0.25%

trypsin-EDTA was added to each flask and placed in the incubator for 75 seconds. After
gently taping the flask to remove any adhered cells, 10 mL of media was added to each
flask. The contents of all flasks were added to a single flask. The approximate number of
cells was calculated using the Nexcelom Bioscience Auto T4 Cellometer cell counter.
The flask containing the cells was diluted to have a concentration of 1 x 106 cells per mL.
1 mL of the stem cell/media mixture was added to each well that contained a
nanocomposite and 3 additional empty wells as a control. The media was changed for
each well every 48 hours.
4.2.6

Live/Dead Staining
Cell viability was tested using the Biotium viability/cytotoxicity assay kit. The

staining solution was made by adding 1.25 µl of 4 mM calcein AM and 5 µl of 2 mM
EthD-III to 2.5 mL of PBS. The depleted media was removed from the well and the well
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was washed twice with PBS. 300 µl of the staining solution was added to each well and
allowed to absorb for 1 hour at room temperature in a dark enclosure. Live cells
fluoresced at 517 nm and dead cells fluoresced at 625 nm. A microscope with filters to
allow specific excitation wave lengths of 494 nm and 532 nm was used.
4.2.7

Alizarin Red S Staining
Alizarin Red S staining was done on a plate of samples at an interval of 1, 7, 14,

22, 28, and 35 days. Each well of cells were stained with Alizarin Red S stain to
determine if the cells were calcium-rich, indicating that the stem cells are beginning to or
have already become pre-osteoblast or pre-chondroblasts. A 40 mM Alizarin Red S
staining kit was purchased from Sigma-Aldrich. The pH of the alizarin red s was adjusted
to 4.2 before use with the 10% ammonium hydroxide or 10% acetic acid included with
the kit. Media was removed from each well and 300 µl of 10% formaldehyde was added
to each well to fix the cells for 10 minutes at room temperature. The formaldehyde was
removed, and the well was washed with 500 µl PBS twice to remove as much
formaldehyde as possible. 250 µl of alizarin red s was added to each well and allowed to
stain for 15 minutes at room temperature. The final step was to wash the well with water
prior to observing under a microscope.
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4.3 Results
4.3.1

FITC/BSA Calibration Curve
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Figure 4-1: Graph of the calibration curve of FITC/BSA in PBS to determine the amount
of FITC/BSA released from the nanocomposite over time.
4.3.2

FITC/BSA Released into Solution
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Figure 4-2: Graph of FITC/BSA released from cylindrical nanocomposites after
degradation. Error bars represent ± standard deviation. (n=6)
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Figure 4-3: FITC/BSA released into solution after nanocomposite degradation over 4weeks. (n=6)
4.3.3

Live/Dead Staining

Figure 4-4 Live dead assay of the control wells showing the live cells in green on top
image and dead cells in red on the image below for day 1, 7, 14, 21, and 28.
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Figure 4-5: Live dead assay of wells containing HNT\PLA discs showing the live cells in
green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and 28.

Figure 4-6: Live dead assay of wells containing TGFβ1\PLA discs showing the live cells
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and
28.
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Figure 4-7: Live dead assay of wells containing TGFβ2\PLA discs showing the live cells
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and
28.

Figure 4-8: Live dead assay of wells containing TGFβ3\PLA discs showing the live cells
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and
28.
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Figure 4-9: Live dead assay of wells containing BMP2\PLA discs showing the live cells
in green on top image and dead cells in red on the image below for day 1, 7, 14, 21, and
28.

Figure 4-10: Live dead assay of wells containing silicon nitride\PLA discs showing the
live cells in green on top image and dead cells in red on the image below for day 1, 7, 14,
21, and 28.
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Figure 4-11: Graph showing the quantitative values of cell count calculated
((live - dead) / live). Error bars are standard deviation where n=3.
4.3.4

Alizarin Red S Staining

Figure 4-12: Alizarin Red S staining of each well after days 1, 7, 14, 21, and 28 days of
exposure to nanocomposite.
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Figure 4-13: Alizarin Red S staining of each well after 35 days of exposure to
nanocomposite.
4.4 Discussion and Conclusions
4.4.1.

FITC/BSA Release
In this experiment, human mesenchymal stem cells were exposed to PLA

nanocomposite containing HNTs doped with various growth factors. Preliminary results
on the 3D printed nanocomposites doped with FITC/BSA showed consistent results for
the 6 samples that were tested for each period of degradation. Analysis of the release of
the FITC/BSA contained within the printed nanocomposite revealed a release pattern that
showed an initial slow release and increased as the polymer began to undergo hydrolysis.
To calculate the FITC/BSA released into the PBS, the slope of the line in the calibration
curve was used and the number was doubled to account for the sample size of 2 mL.
Figure 4-3 shows the total amount of FITC/BSA released into solution. Growth factor
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release should follow the same pattern of release due to the similar size and external
charges of BSA and the growth factor proteins.
4.4.2

Live/Dead
Live dead staining was performed on all samples to reveal the nanocomposite’s

cytotoxic effects on the stem cells. The results revealed that not only were the
nanocomposites non-cytotoxic, but they were also a desirable location for cell growth.
Clustering and cell migration at or near the edge of the nanocomposite made this
conclusion evident. It is believed that the release of growth factor facilitated the
agglomeration of cells near the nanocomposite. There was no major decline in the ratio of
live to dead cells over the entirety of the 28-day cytotoxicity study. The results were
expected since none of the additives nor the polymers were found to be cytotoxic in tests
performed on the individual components. In vitro cytotoxicity testing using mesenchymal
stem cells give confidence that future test using animal models for in vivo testing would
exhibit similar noncytotoxic effects.
4.4.3

Alizarin Red S Staining
The Alizarin Red S staining was performed in on the cells of all wells including

the control cells. Although the nanocomposites were predegraded with sodium hydroxide
to add texture, no further preconditioning was done. A small quantity of growth factor
was released into solution over the first 4 weeks of the test, thus there was not much
differentiation in the stem cells. Additionally, research has shown that differentiation into
the lineage of osteocytes typically shows calcium deposits only after 28 days. The minute
quantity of growth factor that was released aided in cell recruitment, which was evident
due to the proximity of the cell clusters to the nanocomposite. The differentiation study
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was planned to be concluded after day 28, however, an additional plate remained and was
allowed to proliferate and differentiate for an additional 7 days to see post-28-day
calcium deposits. Contamination was present in all 3 undoped HNT/PLA nanocomposite
wells for the day 35 reading, so images of those sample were unattainable. The wells that
contained TGFβ1, TGFβ2, TGFβ3, BMP2, and silicon nitride all had cells that had
elevated levels of calcium deposits, indicating that cells were differentiating into
osteocytes or chondrocytes.
Our hypothesis was supported with the evidence provided by the live/dead and
Alizarin Red S staining assays. Our nanocomposites released growth factor or silicon
nitride over time and were seen to be non-cytotoxic to mesenchymal stem cells while
promoting osteogenic differentiation. The release of the morphogenic agent contained
within the polymer nanocomposites have been proven to foster cell proliferation,
migration, and differentiation due to direct exposure.
4.5 Future Studies
Additional testing will be done on nanocomposites of the same material that have
undergone more significant hydrolysis. A higher degree of degradation has multiple
effects on cell morphology and structure. Cells may be able to integrate into a
nanocomposite and grow in 3 dimensions. Additionally, a steady supply of growth factor
will be available to continue the signaling cascade that would lead to osteogenic
differentiation. The present study tested the ability of each growth factor to facilitate cell
migration and differentiation individually. Future research will combine growth factors to
harness each growth factor’s ability to impact cell development synergistically.
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Additional western blot testing will be used to specifically confirm the presence
of ALP++, osterix ++, or osteopontin which are proteins that are produced by immature
osteoblasts. Epiphycan (Epyc) and unique cartilage matrix-associated protein (Ucma) are
proteins that can confirm the presence of immature chondrocytes will also be tested.

CHAPTER 5
ANTIBACTERIAL 3D FILAMENT
AND MASK FILTER
5.1 Introduction
The spread of bacteria and viruses can be facilitated through touch or airborne
contact. Infectious diseases or complications with preexisting ailments may result from
exposure to these pathogens. Infectious diseases are a leading cause of mortality
worldwide, with viruses making a significant global impact on healthcare and socioeconomic development. Currently, COVID-19 is a worldwide health pandemic that
affects the world similarly to the 1918 influenza pandemic that claimed an estimated
50,000,000 lives. The recent onslaught of the COVID-19 epidemic, caused by a novel
coronavirus, has affected every facet of human life in some way. Densely populated
buildings such as prisons, assisted living homes, and hospitals reported thousands of
cases [67]. The COVID-19 pandemic has caused severe disruptions to human
communities in employment, medical supplies, household supplies, food and food
services, mental health, and many more. Life will be different for the foreseeable future
in these uncertain times.
The human mouth and nose act as a susceptible environment for viral entry and
incubator for multiple viruses [68]. The nasal epithelium is one of the first sites of

66

67

infection for the SARS-CoV-2 virus [69]. Investigations into the expression of the cell
surface enzyme angiotensin-converting enzyme 2 (ACE2) have been conducted, showing
binding to a SARS-CoV-2 spike protein [69]. The combination of ACE2 and the spike
proteins promote the virus’s internalization into human cells [69]. The presence of virus
binding receptor ACE2 expressed by the mouth and throat epithelial cells makes the virus
binding challenging to prevent [70], [71]. The spike protein on the surface of
coronaviruses multifunctional molecular machine mediates coronavirus entry into host
cells [72]. It first binds to a receptor on the host cell surface through its S1 subunit and
then fuses viral and host membranes through its S2 subunit. Two domains in S1 from
different coronaviruses recognize various of host receptors, leading to the viral
attachment [72]. Recent research has shown evolutionary advantages of the virus in
binding to the host surface, longer-lasting, and increased active receptor sites in humans
[73], [74].
The transmission of COVID-19 is thought to occur through respiratory droplets.
Current CDC guidelines recommend using N95 masks for health care providers
managing the care of patients infected with SARS-CoV-2 or persons under investigation
(PUI) for COVID-19 [75], [76]. Recent studies have revealed that the aerosolization of
SARS-CoV-2 is detectable in the air, and the virus remains viable for up to 3 hours [67].
The global shortage of PPE in the setting of a viral pandemic has created potentially
dangerous conditions for frontline healthcare workers lacking appropriate protection and
their patients [77]. In the spring of 2020, there existed a shortage of N95 masks, surgical
masks, and face shields at hospitals for medical responders testing and treating COVID-

68

19 patients. Medical responders need to be protected from respiratory droplets from
coughing and sneezing in a stressful and intense hospital setting [78].
COVID-19 particles range from 60-140 nm, while N95 masks filter particles at
300 nm and only 95 percent of test particles. N99 respirators filter particles at 100 nm,
and without inactivating pathogen particles. Any smaller particles that are filtered by the
N95 or N99 mask is done so by electrostatic forces. Additionally, the respiratory droplets
that are thought to carry the viral particles are larger than the size of the viral particles
themselves and may also be caught by current masks. However, individuals with chronic
respiratory, cardiac, or other medical conditions may have difficulties wearing N95
masks for extended periods due to labored breathing. Due to the high similarities of
previous novel coronaviruses, it is believed that immunocompromised individuals,
elderly, and patients suffering from chronic or acute respiratory illness remain highly
susceptible to the onset of symptoms and higher mortality rates among the general public
[79], [80]. The virus’s virulent nature remains a threat to all of society as all age groups
have been impacted in some capacity. Moreover, N95 respirators are not designed for
children or individuals with facial hair. Because of these inherent gaps in capability, a
new mask must be developed for increased protection against viral pathogens while also
taking other considerations into hand such as comfortability and mask related health risks
and prevention.
The need for advanced protective masks continues to mount each day for
healthcare professionals worldwide, with no signs of stopping, even with the control of
the current COVID-19 pandemic. Because the future timing of outbreaks is unknown,
developing a mask that protects a wider scope of wearers in a clinical or domestic setting
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remains a high priority. All healthcare personnel, ordinary citizens, and our servicemen
and their families should not have to resort to homemade apparatus that are potentially
leaving them at risk to inhale pathogens and are not entirely effective at preventing the
spread of viral particles [81]. Even though many individuals and groups are designing
and manufacturing face shield frames for these responders using personal 3D printing
machines, many designs are not implemented for high-density optimized additive
manufacturing and cannot be accessed locally [81], [82].
N95 respirators are personal protective equipment that is used to protect the
wearer from airborne particles and liquid. An N95 respirator is a respiratory protective
device designed to achieve a very close facial fit and very efficient airborne particles’
filtration. Some N95 respirators are intended for use in a health care setting and worn by
health care personnel during procedures to protect both the patient and health care
personnel from the transfer of microorganisms, body fluids, and particulate material as
well as filtering specific amounts of viruses or bacteria, reducing the amount of but not
actively killing viruses, bacteria, or fungi [83]–[86]. A recent publication noted coinfection with other respiratory pathogens was as high as 21% [87]. Surgical masks are
designed to prevent others from becoming infected due to airborne particles and liquids
expelled from the wearer. There is a common misconception that surgical masks provide
adequate wearer protection from the inhalation of harmful microorganisms. Surgical
masks are used to protect a patients’ wounds from aerosol or mucosal droplets that may
contain harmful microorganisms and offer little respiratory protection for the user [88].
The respiratory system is not the sole means of infection by COVID-19 or other
bacteria and viruses. Surfaces can harbor various pathogens transmitted to the body by
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transferring to the skin from a surface and into the body through any orifice or lesion.
Research has shown that the attachment of bacteria to horizontal surfaces may stimulate
bacterial growth [89]. This is due to the increased nutrient deposits as organic material
tends to settle on its surface [89]. Additionally, metabolites and co-factors may be
obtained from these surfaces and can lead to biofilms, which protect the bacteria.
Biofilms provide resistance to mechanical damage, dislodgement due to liquid or airflow,
and antibiotic treatment resistance [89], [90]. Care must be taken to prevent bacteria from
producing exopolysaccharide matrix or glycocalyx which are critical components of
biofilms. A substance that can kill or disable pathogens in a short period is crucial to
fighting bacterial, fungal, and viral infections.
The interaction of metal nanoparticles (mNPs) with microorganisms offer many
advantages for therapeutic applications. The unique physical properties of mNPs have
associated benefits for drug delivery [91]. These are predominantly due to the particle
size (which affects bioavailability and circulation time), large surface area to volume
ratio (enhanced solubility compared to larger particles), the particle’s tunable surface
charge with the possibility of encapsulation, and excessive drug payloads that can be
accommodated [92], [93]. Metals such as silver and copper exert toxicity at inherently
low concentrations that are non-toxic to mammalian cells [94]. It is believed that copper
kills bacteria by releasing copper cations and reactive oxygen species that disrupt cellular
activity [95]. The ability to cross bacteria cell membrane and damage vital enzymes are
the properties that make copper nanoparticles an effective antibacterial material.
Research has shown that silver nanoparticles damage the bacteria’s outer membrane by
inducing pits and gaps that fragment the cell [96]. Zinc nanoparticles’ antibacterial
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mechanism is not fully understood, but they have been shown to cause morphological
changes, membrane leakage and an increase in oxidative stress gene expression [96].
When mNPs particle size is reduced, this amplifies the toxicity even at low levels
and increases their prokaryotes’ effects [93]. Combinations of silver, copper, and zinc
nanoparticles exhibit synergistic antimicrobial activity, which can be attributed to
increased prokaryotic cell permeability [94]. Furthermore, when mNPs are combined
with antibiotics and doped into polymers, they have shown a similar augmented
antimicrobial effect [94], [97].
In response to the COVID-19 pandemic, we designed an antimicrobial filter and
mask tandem filtration unit made of medical-grade bioplastics and metal/ceramic
nanoparticle composites. The filter utilized in our design aimed to possess a porosity of
50nm due to the nature of the electrospun fibers that form a “spider-web-like” material
that is breathable and long-lasting. The filter material is similar to the mask’s material
except for the quantity of mHNTs and manufacturing method. Our first application of this
filter system was as a replacement to N95 respirators. Critical in our design concept was
to fabricate a fluid resistant filter unit that provides the wearer protection against large
droplets, splashes, or sprays of bodily or other hazardous fluids. It also protects the
patient from the wearer’s respiratory emissions and reduces the wearer’s exposure to
particles, including small particle aerosols and large droplets.
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5.2 Materials and Methods
5.2.1

Fabrication Design

The filtration units were fabricated in a variety of sizes with rigid or elastic
thermoplastics. Polylactic acid (PLA) and thermal plastic urethane (TPU) were the
polymers of choice to manufacture the filtration unit’s mask portion. PLA was the only
thermoplastic used for the filter systems. Filters are composed of a commercially
available gauze, thermoplastic, and mHNTs. We have a patented method for metalizing
the HNT surface with antimicrobial metals (copper, silver, zinc, and others). 3D printing
will assemble the masks in a layer-by-layer fashion. It affords a significant ability for
customization with different metal-coated HNTs (mHNTs), antimicrobial-loaded HNTs,
and antimicrobial-loaded mHNTs. The filters also carry an electrostatic charge to attract
small enough particles enough to pass through the filter’s pores.
5.2.2

Inner and Outer Fabric Layers of the Filter
Many N95 masks utilize a triple-ply approach to manufacture their respirators.

These three-ply materials are typically made of an outer layer of bonded fabric, a
filtration layer comprised of melt-blown material, and an inner layer made of more
bonded fabric. A similar approach was taken for the manufacturing of the filters for this
experiment. The filter for the mask was also comprised of three layers. The first and last
layers were composed of rayon/polyester wound gauze pads (Equate, Bentonville, Ar.).
The inner layer was comprised of blow-spun PLA/mHNT. A multilayered approach to
manufacturing the filters offers an improved ability to filter particles in both airflow
directions during inhalation and exhalation. Furthermore, the inner layer can be made
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double thick to add more filtering capability by coating both gauze pieces with blow-spun
material.
5.2.3

Material Preparation and Filament Extrusion

5.2.3.1

Metal HNT Preparation
A non-sacrificial standard two-electrode electrolysis setup was assembled

consisting of two platinum-coated titanium mesh electrodes acting as a reversible cathode
and anode. The electrodes were gently cleaned using silicon carbide abrasive papers and
ultrasonicated in distilled water for 10 minutes to remove any surface contamination. The
electrodes were held parallel at a 2-inch distance and connected to a DC power source
(VWR Accupower 500 electrophoresis power supply).
An ultrasonicated colloidal solution of 700 mL of 5mM (AgNO3, CuSO4 or
ZnSO4 respectively) and 350 mg HNT were dispersed in the electrolysis vessel (1000 mL
VWR borosilicate glass beaker) and continuously stirred using a magnetic stir bar to
reduce electrophoretic buildup and precipitate formation at the working electrode. A
temperature of 85°C during the duration of the electrolysis process. The 20V charge was
applied in 5-minute intervals, after which the polarity was reversed. This process
continued for a total of six 5-minute cycles for a total of 30 minutes.
The supernatant was decanted and washed with deionized water three times. The
solution was centrifuged at 2000 rpm for 5min with water to separate mHNTs from the
unreacted NPs. The supernatant was removed. The unreacted NPs collect on top of the
dense pellet after centrifugation and were removed. The mHNTs were then dried at 37°C.
A schematic of the set up can be seen in Figure 5-1.
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Figure 5-1: Schematic of the halloysite metal coating process.
5.2.3.2
HNT and mHNT PLA Filament Preparation
Five compositions were tested in this study: PLA, PLA+mHNTs/Zn,
PLA+mHNTs/Cu, PLA+mHNTs/Ag, and PLA+mHNTs/(Ag,Cu,Zn). Filaments were
extruded using a Noztek Pro Extruder (West Sussex, England) with a uniform diameter of
1.75 ±0.05mm, but there was a slightly different filament preparation for each group. For
the PLA group, PLA filaments were extruded at 175°C. For PLA+mHNTs groups, to
archive a uniform distribution of HNTs in PLA, 20µL of PEG 200 was added into 20g
PLA and vortexed for 10 minutes, then 1g of Zn, Cu, or Ag mHNTs were added and
continually vortexed for another 10 minutes. For PLA+mHNTs/(Ag,Cu,Zn) mixture,
0.33g of each respective mHNT type were combined before adding them to the PEG
coated PLA. All mixtures of PLA+mHNTs were extruded at 181°C. Prior to extrusion,
all compositions were allowed to pre-dry for 4hrs in an incubator at 60°C as per the
manufacturer’s instructions to yield a more uniformed extrusion.

75

5.2.4

3D Printing of Masks

3D printing of the masks was done on an Ender 3 (Shenzhen, China) 3D printer with
most of the general settings. The mask’s design was produced using the free computeraided design (CAD) website TinkerCAD.com and converted to a stereolithography (.stl)
file. Ultimaker Cura 4.5 was used to adjust design parameters and create the g-code. Each
mask was printed 205°C with an infill ratio of 50 % and the print platform heated to 50°C
to aid in bed adhesion.
5.2.5

3D printing of Testing Discs

Each filament was printed into test discs for bacterial studies using a Creality ENDER
3 Pro (Shenzhen, China) 3D printer with similar settings. Due to the addition of the
mHNTs, a slightly higher temperature was needed to print the testing discs successfully.
PLA filament was printed at 205°C, while the PLA/mHNT filament was printed at
210°C. The test discs were cylindrical, with a height of 2mm and a diameter of 6mm for
an overall surface area of 94.25mm2. The infill ratio of the discs was 100% to make a
solid disc with minimal porosity.
5.2.6

Antibacterial Testing

Bacterial cultures were prepared to test the pre-extruded and 3D printed filament’s
ability to inhibit bacterial growth. Antibacterial testing was done on both GS doped
mHNTs and undoped mHNTs. The pre-extruded non-doped and doped mHNTs were
subjected to Mueller-Hinton broth testing. Muller-Hinton agar plates and Muller-Hinton
broth test tubes were used to provide testing mediums for the antibacterial capabilities of
the printed non-doped and doped mHNTs. Gentamicin reference discs were plated to give
a reference for the zone of inhibition on the agar plates.
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5.2.6.1

Muller-Hinton Broth

Liquid medium testing was facilitated using Mueller-Hinton broth. 5 mL of MullerHinton broth was added to each glass test tube and autoclaved. Once the broth cooled
overnight, samples were marked for each polymer sample. We used E. coli and S. aureus
as a model gram-negative and gram-positive bacterial source. Testing was performed on
mHNT coated PLA beads, gentamicin doped mHNTs coated PLA beads, 3D printed nondoped mHNT PLA discs. Finally, 3D printed gentamicin doped mHNTs PLA discs.
Glass culture tubes were inoculated with 50 µL of E. coli or S. aureus after each
respective mHNT or doped mHNT bead or disc was added to the broth of each tube.
Controls of uninoculated Muller-Hinton broth and inoculated broth were used. The
cultures and controls were incubated at 37°C for 48 hrs. Optical density for the nondoped mHNT coated PLA beads readings were taken for at the 0 and 48 hr marks.
Readings were taken for the GS doped mHNTs beads and discs at the 0, 24, and 48 hr
mark. Each test was done in triplicate and the results were averaged.
5.2.6.2

Muller-Hinton Agar

Muller-Hinton agar plates were prepared for manufacturers’ specifications. We used
E. coli and S. aureus as gram-negative and gram-positive bacterial sources. Testing was
performed on 3D printed gentamicin doped mHNTs PLA discs. Each respective filament
blend was printed into the small cylindrical disc described above. Each polymer was
plated added to the bacteria covered agar plates before a 24 hr incubation at 37°C. zone
of inhibition measurements was taken using a digital caliper. Each test was done in
triplicate and the zone of inhibition diameters were averaged.
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5.2.7

Blow Spinning Fibers

A mixture of 10 mL dichloromethane (DCM), PLA, and mHNTs were combined and
ultrasonicated for 20min. The solution was then left for 48 hr at room temperature. A
Zeny gravity feed airbrush kit was used with the air pump set to maintain a constant
pressure of 40-60psi as our blow spinner. A square (4in x 4in) of sterile gauze as attached
to the spraying platform. 4 mL of the DCM/PLA/mHNT solution was evenly airbrushed
onto the surface of the gauze. The gauze was fully dry overnight at room temperature.
Two squares were placed together with the airbrushed sides facing each other to make a
four-layer filter. An unsprayed gauze square was used to sandwich the blow-spun layer of
another gauze square to make a three-layer filter.
5.2.7.1

Blow-Spun Fiber Concentrations

Three different mixtures of DCM, PLA, and mHNT were used to compare the
surface’s appearance to determine which was more uniformed. Each mixture contained
10 mL of DCM and varying amounts of PLA and mHNT. The concentrations of PLA in
DCM were 0.1 g/mL, 0.075 g/mL, and 0.05 g/mL. Each mixture contained twenty
percent mHNT by weight concerning the amount of PLA. Using 4 mL of the solution,
theoretically 400 mg, 300 mg, and 200 mg of PLA with 80 mg, 60 mg, and 40 mg of
mHNT was deposited onto each square of gauze respectively.
5.2.7.2

Blow-Spun Fibers with Varying Amounts of mHNTs

Filters with varying amounts of mHNTs were made to test the dispersion of copper
across the surface of the filters. 10 mL of DCM was added to three 50 mL glass vials
along with 500 mg of PLA. 50 mg, 100 mg, and 150 mg of CuHNTs were added to each
respective glass vial to make a 10%, 20%, and 30% mHNT to PLA solution. 3 mL of
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each solution was blow-spun onto a 4x4 inch gauze square and allowed to dry at room
temperature for 24 hours before analysis.
5.2.8

Distribution of mHNTs in the Filter

The blow-spun fibers using PLA, dichloromethane and mHNTs were blown onto
gauze, an analysis of the distribution of mHNTs was performed. SEM and EDS imaging
were used to examine the fibers and map the distribution of the mHNTs on the surface of
the blow-spun material.
5.2.9

Filter Imaging

5.2.9.1

Scanning Electron Microscope (SEM)
The mHNTs and filters were imaged with the SEM to characterize the texture of

the surface. The filters’ surface topography will give an insight into how the blow-spun
fibers are oriented and show prominent pores near the surface. SEM images will confirm
that the HNTs are coated with metal nanoparticles.
5.2.9.2

Energy Dispersion Spectroscopy (EDS)

The mHNTs and filters were imaged and analyzed with the EDS to further
characterize the texture of the surface and show the dispersion of metal on their body.
The distribution of metal on the surface of the filters can be displayed and quantified to
represent the entirety of the filter. The EDS will confirm and quantify that the mHNTs
are coated in metal nanoparticles.
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5.3 Results
5.3.1

SEM of mHNTs

Figure 5-2: Scanning electron microscope image of A) silver, B) copper, and C) zinc
coated halloysite nanotubes.
The SEM images shown in Figures 5-2 A-C show a thin, uniformed coating of metal
on the outside surface of the HNTs. Excess agglomerated zinc particles were seen in the
image. These particles were unable to be washed away using additional washing. The
following EDS images confirm the presence of each metal on the surface of the
halloysite.
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5.3.2

EDS of mHNTs

Figure 5-3: Energy dispersion X-ray spectroscopy scan of A) silver, B) copper, and C)
zinc coated halloysite nanotubes.
EDS analysis of the highlighted boxes Figure 5-5 A-C revealed a quantitative weight
of ~6% for silver nanoparticles, ~5% for copper nanoparticles, and ~8% for zinc
nanoparticles. Due to the unpredictable nature of the metal coating process, a variance in
the amount of coating per nanotube is not unpredictable. Large clusters of copper and
zinc nanoparticles were not observed as seen previously in silver samples.
5.3.3

Liquid Growth Inhibition Studies
The absorbance values for each Mueller-Hinton broth culture were measured at

630 nm. The results for the 48h mHNT coated PLA beads are shown in Figure 5-4. The
optical densities for the 24h and 48h bacteria cultures in Mueller-Hinton broth that
contained GS doped mHNT coated PLA beads are shown in Figure 5-5 and Figure 5-6.
Figure 5-7 and Figure 5-8 show E. coli and S. aureus’s growth pattern when exposed to
PLA beads coated in GS doped mHNTs. Optical density is directly correlated to the
turbidity of the broth. Higher turbidity is evidence of a higher amount of bacterial growth.
As such, the control broth for each set of cultures yielded the highest optical densities.
This is observed for E. coli and S. aureus cultures at the 24h and 48h readings.
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The optical densities for the 24h and 48h bacteria cultures in Mueller-Hinton
broth that contained GS doped mHNT 3D printed discs are shown in Figure 5-9 and
Figure 5-10. Figure 5-11 and Figure 5-12 show the growth pattern of E. coli and S.
aureus when exposed to GS doped mHNTs discs. A higher turbidity was also observed in
both cultures when using GS doped mHNT discs.
In the experiments done with GS doped mHNT covered PLA beads and 3D
printed GS doped mHNT embedded PLA discs, the cultures were also done with HNT
covered PLA beads and 3D printed PLA embedded with HNT to see the effects of plain
HNTs on bacterial growth. The resulting studies showed little to no growth inhibition of
either E. coli or S. aureus. The GS doped mHNT coated beads showed little to no
bacterial growth after an incubation period of 24h and 48h. The results of the bacterial
studies done with 3D printed GS doped mHNT embedded PLA discs showed a higher
optical density than the GS doped mHNTs covered PLA beads in E. coli and S. aureus.
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Figure 5-4: PLA beads coated with mHNTs in Mueller-Hinton broth for 48h with E. coli
or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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Figure 5-5: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 24h with
E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent
± standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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Figure 5-6: PLA beads coated with doped mHNTs in Mueller-Hinton broth for 48h with
E. coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent
± standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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Figure 5-7: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for
48h with E. coli. Optical density readings were taken at 0, 24, and 48h. Optical
density was taken at 630nm wavelength. Error bars represent ± standard deviation.
(n=3)
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Figure 5-8: PLA beads coated with GS doped mHNTs in Mueller-Hinton broth for
48h with S. aureus. Optical density readings were taken at 0, 24, and 48h. Optical
density was taken at 630nm wavelength. Error bars represent ± standard deviation.
(n=3)
The 3D printed PLA discs were subjected to identical testing conditions as the mHNT
and GS doped mHNT coated beads. The results can be seen in Figures 5-9 through 5-12.
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Figure 5-9: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 24h with E.
coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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Figure 5-10: GS doped 3D printed mHNTs discs in Mueller-Hinton broth for 48h with E.
coli or S. aureus. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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Figure 5-11: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for
48h with E. coli. Optical density readings were taken at 0, 24, and 48h post
inoculation. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. (n=3)
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Figure 5-12: 3D printed PLA with GS doped mHNTs in Mueller-Hinton broth for
48h with S. aureus. Optical density readings were taken at 0, 24, and 48h post
inoculation. Optical density was taken at 630nm wavelength. Error bars represent ±
standard deviation. (n=3)
5.3.4

Plate Growth Inhibition Studies
The zone of inhibition for undoped mHNTs in PLA discs is displayed in Figure

5-13. The pictures from Figure 5-14 and 5-15 display the zone of inhibition of the
different formulations of 3D printed GS loaded mHNT PLA discs. A positive control
lawn of bacteria was used for both E. coli and S. aureus to display the ability to grow on
the Mueller-Hinton agar plates. Each control plate had full coverage across the entire
surface. A PLA disc embedded with plain HNTs was also plated to show any
antibacterial properties of plain HNTs. Figure-16 shows the average zone of inhibition
for each respective 3D printed GS loaded PLA disc.
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Figure 5-13: Zone of inhibition diameter average for each respective 3D printed discs
after 24h. Error bars represent ± standard deviation. Values had a significant difference
unless denoted (p<0.05). (n=3)

Figure 5-14: Mueller-Hinton agar plates, plated with E. coli, and (A) nothing, (B)
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E)
3D printed GS/Zn/HNT disc, (F) 3D printed GS/Ag,Cu,Zn/HNT disc.
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Figure 5-15: Mueller-Hinton agar plates, plated with S. aureus, and (A) nothing, (B)
PLA/HNT, (C) 3D printed GS/Ag/HNT disc, (D) 3D printed GS/Cu/HNT disc, (E) 3D
printed GS/Zn/HNT disc, (F) 3D printed GS/Ag,Cu,Zn/HNT disc.
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Figure 5-16: Zone of inhibition diameter average for each respective 3D printed
discs after 24h. These were GS loaded mHNTs. Error bars represent ± standard
deviation. Values had a significant difference unless denoted (p<0.05). (n=3)
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5.3.5

Filter SEM and EDS

Figure 5-17: SEM of filter using the 0.1g/mL mixture PLA solution.

Figure 5-18: SEM of filter using the 0.075g/mL mixture PLA solution.
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Figure 5-19: SEM of filter using the 0.05g/mL mixture PLA solution.
Fast scan SEM imaging was used to obtain the above images. Slower scanning
or higher amounts of scans would have deformed the filter due to thermal energy
imposed upon by the electron emitted from the SEM.

Figure 5-20: EDS of 10% CuHNT to PLA blow-spun fibers.
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Figure 5-21: EDS of 20% CuHNT to PLA blow-spun fibers.

Figure 5-22: EDS of 30% CuHNT to PLA blow-spun fibers.
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Figure 5-23: Graph showing the coverage of representative piece of each filter.
Error bars represent standard deviation. Values had a significant difference unless
denoted (p<0.05). (n=3)
5.4 Discussions
5.4.1

Analysis of GS/mHNTs

The EDS scans confirmed the addition of each metal to the surface of the halloysite
nanotube. The color rendered images illustrated that each metal was deposited evenly on
all nanotubes and was on the surface even after vacuum loading with gentamicin.
Minimal contamination of unbound nanoparticles was observed. The presence of high
concentrations of each specific metal nanoparticle in the area exhibiting high
concentrations of the halloysite’s outer surface’s silicone confirmed this result. In
samples with high amounts of contamination, large pockets of agglomerated
nanoparticles with little to no silicone present.
5.4.2

Antibacterial Studies
The antibacterial capabilities of mHNTs and GS doped mHNTs were tested in a

series of experiments using both gram-positive and gram-negative bacteria. All iterations
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of mHNT show a hindrance to bacterial growth. Vacuum loading mHNTs with GS
offered a more remarkable ability to inhibit bacterial growth. As seen in Figures 2 and 3,
the non-3D printed GS loaded mHNT coated PLA beads could better inhibit bacterial
growth than the 3D printed GS loaded mHNT discs. We speculate that since the entire
load of GS loaded mHNTs was on the surface of the beads, more of the nanoparticles and
gentamicin were available to deter bacterial growth. The 3D printed discs were made
with extruded filament containing the GS loaded mHNTs. The GS loaded mHNTs were
dispersed within the filament and thus mainly within the 3D printed discs. With the
nature of the dispersion, some GS loaded mHNTs were present on the 3D printed disc’s
surface to inhibit bacterial growth. We observed that the GS loaded mHNTs could inhibit
bacterial growth more than the gentamicin control disc. It is believed that the synergy of
the loaded gentamicin and the metal nanoparticles made this possible.
While the coated beads performed better than the 3D printed discs, they will lose
their ability to be an effective bacterial deterrent over time. The nature of the 3D printed
discs is such that they wear down over time. This wearing effectively discards the now
empty mHNTs and exposed new ones to the surface thus keeping its antimicrobial
properties. The principle of a renewed antimicrobial outer surface has benefits for
manufacturing products like masks, light switches, and toilet handles. The advent of
utilizing this technology to manufacture objects with questionable sanitation could lower
the ability to transmit microorganisms.
Medical facilities, such as hospitals or clinics, could see the most benefit from
using antimicrobial surfaces to help fight the spread of infections like MRSA. Surfaces
are periodically sanitized in medical facilities; however, there are gaps when these
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surfaces are not cleaned. Surfaces such as doorknobs, water fountains, and water faucet
handles are often touched with little second thought to the possible transfer of germs. An
innate ability to self-sanitize would provide considerably better protection to all who
come into contact.
To produce the quantity needed for mass implementation, two manufacturing
methods can be used, industrial 3D printers or injection molding. Each technique of mass
manufacturing has its advantages and disadvantages. The benefits of industrial 3D
printing are the rapid ability to change the design of the object being printed. The
obstacles that are faced with industrial 3D printing are the slow turnover and increased
porosity. Injection molding has a faster throughput but can typically be harder to adjust
the design.
The GS doped mHNTs and their antimicrobial capabilities can be used to
manufacture more than the face masks and filters tested in this study. Intubation tubes
and catheters can be manufactured with mHNTs to reduce infections in patients caused
by bacterial. Eye guards have been made using mHNTs embedded in polycarbonate or
poly (methyl methacrylate). Clarity was not compromised by implementing the mHNTs
and showed an improvement in strength and antimicrobial capability. Research continues
to be conducted to discover more products that can benefit from the implementation of
mHNTs.
5.4.3

Filter Construction
The SEM images show that the fibers of the filter are long and interwoven

strands. The blow-spun fibers’ complex structure reduces the filter’s porosity, allowing it
to capture or block microscopic particles. Visual analysis each fiber construct’s three
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different concentrations revealed that a higher concentration of PLA in solution would
yield a blotchy, uneven spray pattern instead of fine, uniformed fibers.
The EDS images show that we have an even distribution of mHNTs on the
surface of the filter. The concentration of mHNT on the surface went up as predicted with
higher concentrations of mHNT in solution, with minimal adverse effects such as area
agglomeration. We concluded that the blow-spun fibers at the surface represent the
internal fibers of the filter. With each pass of the airbrush, an additional layer is added of
seemingly the same fiber dispersion.
The EDS images in Figure 5-20, 5-21, and 5-22 showed an even distribution of
CuHNTs filter’s surface. The blow-spun fibers beyond the surface should exhibit similar
patterns of distribution. The varying concentration of CuHNTs influenced the number of
deposited mHNTs. Darkfield analysis of the EDS images showed a decline in the overall
darkness as the concentration of CuHNT increased, meaning more copper was present.
Analysis of the overall intensity of the EDS images of multiple filters revealed that the
coverage of mHNT when using 20% and 30% were similar. The precent of coverage can
be seen in Figure 5-23. These combined results mean the 30% CuHNT was applied more
evenly across the surface. This could be due to having a more homogeneous starting
mixture or merely human error when blow spinning.
5.5 Conclusions
3D printing has emerged as a viable option to manufacture face masks. The
critical design feature in N95 respirators and surgical masks is the filtration unit. We have
an efficient and effective design using 3D printing that can be scaled up for mass
production via injection molding or industrial-scale 3D printers. We have demonstrated
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the capability of our antimicrobial filament to be used to manufacture a mask that has
antibacterial capabilities. GS loaded mHNTs were successfully used to effectively kill or
retard the growth of both gram-negative and gram-positive bacteria on a surface and in
liquid mediums. Mueller-Hinton broth optical density and Mueller-Hinton agar plate
zone of inhibition results support this conclusion. While the mHNTs showed an ability to
hinder bacteria’s growth, the GS-doped mHNTs offered a much greater capacity to kill or
inhibit bacterial growth. Due to the nature of the filament manufacturing and the 3D
processes, careful consideration was taken when choosing the antimicrobial agent used as
a dopant.
Recent concerns about the effectiveness of 3D printed face masks and respirators
have arisen in response to similar designs to our “Montana style mask” made on
commercially available printers. The two major concerns are that the mask’s fit is not
adequate, and the filter is not secured tight enough. We modified the original design of
the Montana mask to address these issues. We added a layer of soft material to the
masks’ edge to improve comfort and provide a better seal to the wearer’s face. The soft
fabric was made of silicon weather stripping that was glued into place. A rubber foam
material was not used due to porosity and complications with future sanitation. The
silicon can be sanitized with UV light, soap, alcohol, or hydrogen peroxide solutions. The
filter seal was improved by the addition of a small lip onto the front of the mask. The lip
would act as a guard in which you could tightly push the filter and filter guard against the
front of the mask, making a better seal.
Future studies will explore alternative doping materials to customize filament to
have enhanced capabilities such as antifungal, antiviral, antibacterial, anticorrosive, and
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many more within the PLA filament. The addition of different metal nanoparticles and
multiple types of metal nanoparticles to a single HNT could improve the PLA filament’s
antibacterial capabilities. Polyethylene terephthalate glycol (PETG) will be explored as
an alternative option to PLA because it is more robust and durable.
The respirator will soon undergo National Institute of Occupational Safety and
Health (NIOSH) certified fit testing to ensure it passes government regulations for
occupational use within the United States of America. Antiviral studies will be conducted
using two surrogate coronaviruses, mouse hepatitis virus (MHV) and transmissible
gastroenteritis virus (TGEV). Testing will include viral elimination on the filter’s surface
that will be analyzed using an ELISA kit. Additionally, the filter will be tested using a
nebulized virus in a vacuum system to gauge the effectiveness of stopping viral particles
from penetrating through the filter’s blow-spun layers.
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